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Introduction
Sigma1 receptors (σ1Rs) are widely distributed in the brain and 
peripheral tissues, including lung, kidney, liver, and spleen, and 
highly expressed in some tumor cells (Walker et al., 1990; Vil-
ner et al., 1995; Monnet, 2005; Stone et al., 2006; Cobos et al., 
2008; Wu and Bowen, 2008; Su et al., 2010; Brune et al., 2013). 
They are regulated by an unusually diverse array of ligands, 
including endogenous steroids, drugs of abuse such as cocaine 
and methamphetamine, and drugs used to treat depression, anx-
iety, psychosis, pain, and neurodegenerative diseases (Maurice 
et al., 1999; Waterhouse et al., 2007; Maurice and Su, 2009; Su 
et al., 2010; Navarro et al., 2012; Robson et al., 2012; Wünsch, 
2012; Kourrich et al., 2013; Tsai et al., 2014). Changes in ex-
pression and polymorphisms of σ1Rs are associated with heart 
failure (Ito et al., 2012, 2013), addiction (Maurice et al., 2002; 
Kourrich et al., 2013), neurodegenerative and psychiatric disor-
ders (Miki et al., 2014; Tsai et al., 2014), and cancer (Spruce et 
al., 2004; Wang et al., 2004; Aydar et al., 2006; Maurice and Su, 
2009; Crottès et al., 2013). These associations have provoked 
interest in σ1Rs as both therapeutic targets and diagnostic tools 
(van Waarde et al., 2015).
The σ1R is an integral membrane protein with two trans-
membrane domains. It is expressed in the ER, where it is 
concentrated in cholesterol-rich mitochondrion-associated ER 
membrane (MAM) domains and bound to the ER luminal chap-
erone, BiP (Fig. S1; Hayashi and Su, 2003, 2007; Palmer et 
al., 2007). Agonists of σ1R cause it to dissociate from BiP and 
MAM, allowing σ1Rs to move within ER membranes and inter-
act with signaling proteins in the plasma membrane (PM), most 
notably ion channels, thereby regulating their activity (Su et al., 
2010; Balasuriya et al., 2012; Pabba, 2013). Antagonists block 
this effect (Fig. S1 and Table S1). Loss of Ca2+ from the ER can 
also release σ1Rs from their interaction with BiP, freeing them 
to interact with other proteins (Hayashi and Su, 2007). In addi-
tion to regulating the activity of these proteins, σ1Rs can also 
act as chaperones, stabilizing signaling proteins as they traffic 
along the secretory pathway (Tsai et al., 2014). σ1Rs may also 
be expressed in the nuclear envelope (Hayashi and Su, 2005a,b; 
Brune et al., 2013; Mori et al., 2013) and PM (Lupardus et al., 
2000; Aydar et al., 2002; Brune et al., 2013; Balasuriya et al., 
2014a) and may even be secreted into the extracellular space 
(Hayashi and Su, 2003; Su et al., 2010). The interactions be-
tween σ1Rs and ion channels may therefore occur within the 
plane of a membrane (ER or PM) or across ER–PM junctions 
(Hayashi and Su, 2007; Kourrich et al., 2013; Balasuriya et al., 
2014a). Clearly, σ1Rs are important links between diverse li-
gands, physiological stimuli, and many key signaling molecules 
(Hayashi and Su, 2007; Su et al., 2010; Kourrich et al., 2013).
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Receptors that stimulate PLC and formation of inositol 
1,4,5-trisphosphate (IP3) evoke both Ca2+ release from the ER 
through IP3 receptors (IP3Rs) and Ca2+ entry across the PM. At 
MAMs, Ca2+ released by IP3Rs can be rapidly accumulated by 
mitochondria, thereby stimulating oxidative phosphorylation 
(Rizzuto et al., 2012) and promoting cell survival (Cárdenas et 
al., 2010), whereas excessive mitochondrial Ca2+ uptake trig-
gers apoptosis (Mallilankaraman et al., 2012). The association 
of IP3R3s with σ1Rs at MAMs supports the transfer of Ca2+ 
from the ER to mitochondria by curtailing the degradation of 
active IP3R3s (Hayashi and Su, 2007). The increase in mito-
chondrial Ca2+ concentration and resultant boost in oxidative 
phosphorylation are thought to contribute to the prosurvival 
effects of σ1Rs in the central nervous system and cancer cells 
(Lewis et al., 2014). One effect of σ1Rs may therefore be to 
support transfer of Ca2+ from the ER to mitochondria, but this 
transfer also depends on the Ca2+ content of the ER.
The Ca2+ entry evoked by receptors that stimulate PLC is 
usually mediated by store-operated Ca2+ entry (SOCE), which 
is stimulated by loss of Ca2+ from the ER (Parekh and Putney, 
2005; Hogan and Rao, 2015). The reduction in Ca2+ concentra-
tion within the ER is detected by the luminal EF hands of stro-
mal interaction molecule 1 (STIM1), an integral ER membrane 
protein. This causes STIM1 to cluster and accumulate at ER–
PM junctions. STIM1 then binds to Orai1, a Ca2+-permeable 
channel in the PM, and activates it (Lewis, 2007; Soboloff et 
al., 2012; Wu et al., 2014). The contributions of related pro-
teins (Orai2, Orai3, and STIM2) to SOCE are not fully resolved 
(Hoth and Niemeyer, 2013), although STIM2 is usually more 
important than STIM1 for refilling of Ca2+ stores (Brandman 
et al., 2007). Additional proteins, including junctate, CRA CR2, 
and SOCE-associated regulatory factor (SAR AF), also interact 
with STIM1–Orai1 signaling complexes and regulate both ac-
tivation and deactivation of SOCE (Srikanth et al., 2010, 2012, 
2013; Palty et al., 2012; Srikanth and Gwack, 2012, 2013).
We show that σ1Rs constitutively inhibit SOCE and re-
duce the Ca2+ content of the ER and that σ1R ligands modu-
late this inhibition. The σ1R associates with STIM1 in the ER 
and is conveyed with STIM1 to ER–PM junctions after store 
depletion. This association slows the recruitment of STIM1 to 
the junctions and reduces binding of STIM1 to Orai1. Our re-
sults establish that σ1Rs inhibit a ubiquitous Ca2+ entry path-
way and suggest a general model for directed translocation 
of σ1R to its PM targets.
Results
σ1R inhibits SOCE
SOCE in human embryonic kidney (HEK) cells can be activated 
by depletion of intracellular Ca2+ stores using thapsigargin to 
inhibit the ER Ca2+ pump or by stimuli of endogenous receptors 
(e.g., ATP or carbachol) that activate PLC. The contributions of 
Orai1 and STIM1 to SOCE (Parekh and Putney, 2005; DeHaven 
et al., 2009; Soboloff et al., 2012) are clear from the inhibition 
of thapsigargin-evoked Ca2+ entry in HEK cells expressing a 
dominant-negative form of Orai1 (Orai1E106Q; Prakriya et al., 
2006) and the enhancement of SOCE after overexpression of 
Orai1 with STIM1 (Fig. 1, A and B). The initial Ca2+ release 
evoked by thapsigargin was unaffected by these effects of 
Orai1 and STIM on SOCE. Stable expression of a V5-tagged 
σ1R in HEK cells (HEK-σ1R cells) attenuated the Ca2+ signals 
evoked by thapsigargin without affecting expression of Orai1 
or STIM1 (103 ± 5% and 91 ± 8% of wild-type cells, respec-
tively; Fig. 1 C) or the basal cytosolic free Ca2+ concentration 
([Ca2+]c; 45 ± 7 nM and 50 ± 3 nM in wild-type and HEK-σ1R 
cells, respectively). The increase in [Ca2+]c after addition of 
thapsigargin in Ca2+-free medium was reduced by 65 ± 9%, 
and the SOCE detected after restoration of extracellular Ca2+ 
was reduced by 86 ± 4% in HEK-σ1R cells (Fig. 1, D and E). 
The rate of increase of [Ca2+]c during SOCE decreased from 
8.8 ± 0.3 nM.s−1 in wild-type HEK cells to 2.8 ± 0.3 nM.s−1 
in HEK-σ1R cells. SOCE in HEK-σ1R cells was similarly re-
duced across a range of extracellular Ca2+ concentrations (Fig. 
S2 A). The inhibition of both thapsigargin-evoked Ca2+ release 
and SOCE in HEK-σ1R cells was also observed at 37°C (Fig. 
S2 B) and in single-cell measurements (Fig. 1 F). The dimin-
ished SOCE did not result from ineffective store emptying 
because it was unaffected by prolonging the incubation with 
thapsigargin from 10 to 20 min (Fig.  1  E). Indeed, both the 
initial Ca2+ content of the stores (determined by addition of 
ionomycin in Ca2+-free medium, the effects of which are not 
restricted to the ER) and the residual content after thapsigargin 
treatment were reduced in HEK-σ1R cells (Fig. 1, G and H). 
When ATP and carbachol were used to deplete Ca2+ stores via 
endogenous pathways, the Ca2+ release and Ca2+ entry were also 
attenuated in HEK-σ1R cells (Fig. 1, I and J). The lesser Ca2+ 
release evoked by ATP and carbachol in HEK-σ1R cells (52 ± 
8% of wild-type cells) matched the reduced Ca2+ content of the 
stores (59 ± 9%), suggesting that this was responsible for the 
diminished response to PLC-coupled receptors.
To investigate whether sustained depletion of Ca2+ stores 
might itself cause down-regulation of SOCE, HEK cells were 
treated with cyclopiazonic acid (CPA) to reversibly inhibit 
the ER Ca2+ pump for a 2-h period that later experiments (see 
Fig. 3) show is sufficient for σ1R agonists to inhibit SOCE. This 
CPA treatment caused a more substantial depletion of the intra-
cellular Ca2+ stores than was observed in HEK-σ1R cells, but 
a much smaller inhibition of the SOCE evoked by subsequent 
addition of thapsigargin (Fig. 2, A and B). These results estab-
lish that loss of Ca2+ from the ER does not cause the reduced 
SOCE in HEK-σ1R cells.
The smaller increase in [Ca2+]c evoked by SOCE in 
HEK-σ1R cells could result from decreased Ca2+ entry or en-
hanced Ca2+ extrusion. However, rates of recovery from Ca2+ 
signals evoked by carbachol and ATP in Ca2+-free medium 
(measured over matched [Ca2+]c) were unaffected by expression 
of σ1R (half-times, t1/2 = 36 ± 5 s and 32 ± 6 s for wild-type and 
HEK-σ1R cells, respectively). The smaller [Ca2+]c increases in 
HEK-σ1R cells were not, therefore, due to more effective buff-
ering or Ca2+ extrusion. Because most Ca2+ extrusion pathways 
do not transport Mn2+, we used quenching of fura 2 fluorescence 
to measure unidirectional Mn2+ influx through the SOCE path-
way (Fig.  2  C). Thapsigargin, or carbachol with ATP, stimu-
lated Mn2+ entry in HEK cells, consistent with the activation of 
SOCE in response to store depletion. In HEK-σ1R cells, there 
was no change in the rate of Mn2+ entry in response to either 
stimulus (Fig. 2 D). Together, these results establish that stable 
expression of σ1R inhibits SOCE.
Selection of polyclonal HEK cells stably expressing σ1R 
might have propagated cells with different Ca2+ signaling be-
haviors. However, the thapsigargin-evoked increase in [Ca2+]c 
and SOCE and the Ca2+ content of the intracellular stores were 
also reduced in HEK cells transiently expressing σ1Rs (Fig. S2, 
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C–E). The reduced SOCE correlated with the level of expres-
sion of σ1R (Fig. S2, F and G). Translocation of GFP-tagged 
nuclear factor of activated T cells (NFAT) from the cytosol to 
the nucleus requires SOCE (Kar et al., 2011). SOCE stimulated 
NFAT translocation in HEK cells, and the response was atten-
uated to similar degrees in cells stably or transiently express-
ing σ1R (Fig. 2, E and F).
We conclude that expression of σ1R inhibits SOCE by re-
ducing the coupling of empty stores to the activation of SOCE.
Agonists and antagonists of σ1R 
regulate SOCE
The σ1R agonist (+)SKF10047 (Su et al., 2010; Navarro et al., 
2012) and the antagonist BD1047 (Fig. S1; Skuza and Rogóz, 
2006; Gromek et al., 2014) were used to investigate the acute 
effects of σ1Rs in CHO cells and HEK-σ1R cells. In CHO cells, 
σ1Rs are endogenously expressed (Hayashi and Su, 2007). As 
in HEK cells, SOCE was inhibited by transient expression of 
Orai1E106Q, although in CHO cells, the thapsigargin-evoked 
Ca2+ release was also inhibited (Fig. S3 A). In both CHO and 
HEK-σ1R cells, preincubation with BD1047 increased the am-
plitude of the Ca2+ signals evoked by SOCE, whereas the ago-
nist (+)SKF10047 had the opposite effect (Fig. 3, A–D). Neither 
ligand affected SOCE in wild-type HEK cells (Fig.  3, E and 
F), confirming that the effects are mediated by σ1Rs. The tem-
perature dependence and slow equilibration of ligand binding to 
σ1Rs (Yamamoto et al., 2001; Chu and Ruoho, 2016), together 
with the need to load cells with Ca2+ indicators at 20°C, lim-
ited opportunities to investigate the time course of the effects of 
σ1R ligands. Nevertheless, it is clear that treatment with ligands 
for at least 1 h at 37°C before loading cells with Ca2+ indicator 
(1.5 h) in the continued presence of ligands was required to de-
tect significant effects of the ligands on SOCE (Fig. S3, B–D).
In CHO cells, siRNA to σ1R almost abolished expression 
of endogenous σ1R, but this was accompanied by reduced ex-
pression of Orai1 and increased expression of STIM1 (Fig. 3, G 
Figure 1. Inhibition of SOCE by σ1R. (A) Ca2+ signals re-
corded from populations of fluo 4–loaded HEK cells tran-
siently transfected with Orai1E106Q, STIM1 and Orai1, or 
mock transfected (control). Cells were stimulated with 5 µM 
thapsigargin in Ca2+-free HBS before restoration of extra-
cellular Ca2+ (final free [Ca2+], 4 mM). Results show mean 
responses from six replicates. (B) Summary results (n = 3) 
show peak increases in [Ca2+]c evoked by thapsigargin (Ca2+ 
release) and Ca2+ restoration (SOCE). (C) Typical immunoblot 
of σ1R, STIM1, Orai1, and β-actin from 20 µg of solubilized 
protein from wild-type (WT) HEK and HEK-σ1R cells. (D) Ca2+ 
signals evoked by thapsigargin in Ca2+-free HBS and after res-
toration of extracellular Ca2+ to wild-type and HEK-σ1R cells. 
(E) Summary shows responses to thapsigargin (Ca2+ release) 
and SOCE detected after restoring Ca2+ 10 or 20 min after 
thapsigargin (n = 6). (F) Responses from single fura 2–loaded 
HEK cells show fluorescence ratios (F340/F380) after stimulation 
with 5 µM thapsigargin and restoration of 4 mM extracellular 
Ca2+. n = 3, each with ∼45 cells. (G) Ca2+ contents of the 
intracellular stores determined by measuring [Ca2+]c after ad-
dition of 5 µM ionomycin in Ca2+-free HBS before or 10 min 
after treatment with thapsigargin. (H) Summary results (n = 
6). (I) Ca2+ release and SOCE evoked by 100 µM carbachol 
and 100 µM ATP. (J) Summary results (n = 6). *, P < 0.05; 
**, P < 0.01; ***, P < 0.001. Student’s t test (E, H, 
and J) or ANO VA with Tukey’s posthoc analysis (B). 
Results show mean ± SEM.
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and H). The loss of Orai1 could reflect a chaperone role for σ1R 
similar to the stabilization of human ether-a-go-go–related gene 
(HERG) K+ channels by σ1R (Hayashi and Su, 2007; Crottès 
et al., 2011). Alternatively, Orai1 expression may be down- 
regulated through an adaptive feedback mechanism arising 
from the reduced inhibition of SOCE after loss of σ1Rs. Over-
stimulation of SOCE by constitutively active STIM1 was shown 
previously to reduce Orai1 expression (Kilch et al., 2013). De-
spite the reduced expression of Orai1, SOCE was increased 
in CHO cells lacking σ1Rs, and it was then unaffected by (+)
SKF10047 or BD1047 (Fig. 3, I and J). The enhanced SOCE 
in CHO cells lacking σ1Rs was abolished by expression of the 
dominant-negative form of Orai1 (Fig. S3 G), confirming that 
it was mediated by Orai1. SOCE monitored by unidirectional 
Mn2+ entry was also increased in CHO cells treated with siRNA 
to σ1R (Fig. S3, E and F). In normal CHO cells, (+)SKF10047 
reduced the Ca2+ content of the stores, whereas the σ1R antag-
onist BD1047 increased their content to a level that matched 
that of cells without σ1Rs. Neither ligand affected the Ca2+ 
stores in CHO cells lacking σ1Rs (Fig. 3, K and L). Although 
comparison of SOCE-mediated Ca2+ signals in CHO cells with 
and without σ1Rs is compromised by accompanying changes 
in STIM1 and Orai1 expression (Fig. 3, G and H), the analyses 
demonstrate that σ1R ligands are effective only in cells express-
ing σ1Rs, and they establish a constitutive inhibition of SOCE 
by endogenous σ1Rs and an associated reduction in ER Ca2+ 
content in CHO cells (Fig. 3, I-L). Similar results were obtained 
in HEK-σ1R cells: siRNA to σ1R abolished the effects of σ1R 
ligands on both SOCE and the Ca2+ content of the stores; it also 
increased the basal Ca2+ content of the stores and the rate of 
Mn2+ entry evoked by either thapsigargin or by the more physi-
ological stimuli, ATP and carbachol (Fig. S3, H and J).
Determining whether ligands of σ1R are more effective 
before or after depletion of Ca2+ stores was frustrated by the 
need for prolonged preincubations at 37°C for optimal effects 
(Fig. S3, B–D). In a modified protocol, fluo 4–loaded HEK-σ1R 
cells in Ca2+-free Hepes-buffered saline (HBS) were incubated 
with (+)SKF10047 or BD1047 for 2 h at 20°C, with thapsigargin 
added either immediately before the ligands or after the 2-h 
incubation. Under these conditions, where the effects of the 
ligands were much reduced, (+)SKF10047 modestly inhibited 
SOCE, and BD1047 modestly enhanced SOCE, but only when 
added before store depletion (Fig. S3 K). These results suggest 
that σ1R ligands affect an early step in the activation of SOCE.
Breast cancer cells express high levels of σ1Rs (Spruce et 
al., 2004; Wang et al., 2004; Aydar et al., 2006). In MDA-MB-231 
human breast cancer cells, which also express σ1Rs, SOCE 
was enhanced by BD1047 and inhibited by (+)SKF10047 (Fig. 
S4). The Ca2+ content of the stores was also reduced by (+)
SKF10047. Hence, in three cell types, HEK-σ1R, CHO, and 
MDA-MB-231 cells, σ1Rs both inhibit SOCE and decrease the 
Ca2+ content of the ER. The inverse agonist effect of BD1047 
in CHO and MDA-MB-231 cells suggests a constitutive regula-
tion of SOCE and ER Ca2+ content by endogenous σ1Rs.
σ1R and STIM1 associate and move to  
ER–PM junctions after store depletion
Interactions between σ1R and STIM1 in unstimulated cells were 
investigated using HEK cells transiently expressing STIM1-
Myc and σ1R-FLAG. Anti-Myc beads pulled down σ1R-FLAG 
Figure 2. Stable and transient expression of σ1R inhib-
its SOCE. (A) Ca2+ signals evoked by 1 µM thapsigargin in 
Ca2+-free HBS followed by restoration of 4  mM extracellu-
lar Ca2+ in HEK wild-type cells treated with CPA (0.5 µM or 
1 µM for 2.5 h) or HEK-σ1R cells. (B) Summary results show 
peak increases in [Ca2+]c evoked by SOCE or by addition 
of ionomycin in Ca2+-free HBS (n = 3). (C) Populations of 
fura 2–loaded cells were treated with thapsigargin (5 µM for 
10 min) in nominally Ca2+-free HBS before addition of 5 mM 
MnCl2. Results show normalized fluorescence intensity (F/F0) 
for six replicates. WT, wild type. (D) Summary results (n = 3) 
show half-times (t1/2) for fluorescence quenching from unstim-
ulated cells (basal) and cells treated with thapsigargin (5 µM 
for 10 min) or ATP and carbachol (100  µM each for 3.5 
min). (E) Typical images of HEK cells expressing NFAT-GFP 
before and 30 min after addition of 5  µM thapsigargin in 
normal HBS (top). Bar, 10 µm. Images of larger fields (bot-
tom) show thapsigargin-treated HEK wild-type and HEK-σ1R 
cells. Asterisks indicate cells used for analysis. Bar, 20 µm. 
(F) Summary results show nuclear translocation of NFAT-GFP 
before and after treatment with thapsigargin (percentage of 
cells; six independent fields, with between 595 and 660 
cells counted for each condition). *, P < 0.05; **, P < 0.01; 
***, P < 0.001. Student’s t test (D) or ANO VA with Tukey’s 
posthoc analysis (B and F). Results show mean ± SEM.
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from solubilized cell extracts, but only in cells expressing 
STIM1-Myc. Conversely, anti-FLAG beads pulled down 
STIM1-Myc, but only in cells expressing σ1R-FLAG (Fig. 4, 
A and B). Coimmunoprecipitation of σ1R-FLAG with STIM1-
Myc was enhanced by (+)SKF10047 and reduced by BD1047 
(Fig. 4, C–E). These results show that STIM1 and σ1R are as-
sociated in unstimulated cells and that their interaction is reg-
ulated by σ1R ligands. Furthermore, the increased association 
of σ1R with STIM1 evoked by the σ1R agonist (Fig. 4) cor-
relates with the inhibition of SOCE (Fig. 3).
To investigate the intracellular dynamics of σ1R and 
STIM1, we used HeLa cells because they are better suited than 
HEK cells for optical analyses of ER proteins while still lack-
ing detectable endogenous σ1Rs (Fig. 5 A). In cells expressing 
σ1R-EGFP with mCh-STIM1, σ1R-EGFP and mCh-STIM1 
colocalized within the ER (Mander’s correlation coefficient 
Figure 3. Ligands of σ1R modulate SOCE. (A–F) Populations of cells were treated with 25 µM (+)SKF10047 or 10 µM BD1047 before removal of 
extracellular Ca2+, addition of 5 µM thapsigargin, and then restoration of extracellular 4 mM Ca2+ to CHO (A and B), HEK-σ1R (C and D), or wild-type 
HEK cells (E and F). Summary results (B, D, and F) show peak increases in [Ca2+]c after restoration of extracellular Ca2+. The color codes in A apply to all 
panels (A–F). (G) Representative immunoblot from CHO cells transfected with control plasmid or plasmid encoding siRNA for σ1R (siσ1R). (H) Summary 
results show band intensities for the indicated proteins normalized to those from cells treated with control plasmid. (I) Ca2+ signals evoked by addition 
of thapsigargin in Ca2+-free HBS and then restoration of extracellular Ca2+ in CHO cells treated with siσ1R or control plasmid. (J) Summary shows peak 
[Ca2+]c after restoration of extracellular Ca2+ to thapsigargin-treated CHO cells treated with siσ1R or control plasmid. Cells were pretreated with 25 µM (+)
SKF10047 or 10 µM BD1047, as indicated. (K and L) Effects of siσ1R or control plasmid and pretreatment with σ1R ligands on the Ca2+ signals evoked by 
5 µM ionomycin in Ca2+-free HBS. Typical traces (K) and summary results (L) are shown. Legends for L are the same as J. All summary results show mean 
± SEM. n = 3. *, P < 0.05; **, P < 0.01; ***, P < 0.001. ANO VA with Tukey’s posthoc analysis (B, D, F, J, and L) or Student’s t test (H and comparison 
of no treatment conditions in J and L).
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was 0.77 ± 0.03; n = 8; Fig. 5 B). We used total internal reflec-
tion fluorescence (TIRF) microscopy to visualize translocation 
of mCh-STIM1 and σ1R-EGFP in response to thapsigargin. In 
cells expressing mCh-STIM1, thapsigargin stimulated an ac-
cumulation of mCh-STIM1 in puncta immediately beneath the 
PM (Fig. 5 C, top). This is consistent with evidence that store 
depletion causes STIM1 to aggregate into sub-PM clusters, 
where they interact with Orai1 to activate SOCE (Liou et al., 
2007; Wu et al., 2014). In contrast, thapsigargin had no detect-
able effect on the sub-PM distribution of σ1R-EGFP expressed 
alone (Fig.  5  C, bottom). However, when mCh-STIM1 and 
σ1R-EGFP were coexpressed, thapsigargin caused both pro-
teins to accumulate in sub-PM puncta, within which the proteins 
colocalized (Mander’s correlation coefficient was 0.77 ± 0.04; 
n = 8; Fig. 5 D), but expression of σ1R slowed the rate of forma-
tion of the mCh-STIM1 puncta (Fig. 5 E). Rates of formation of 
mCh-STIM1 puncta were unaffected by expression of another 
ER membrane protein, IP3R1 (times to 50% accumulation were 
325 ± 14  s and 342 ± 11  s, with and without IP3R1, respec-
tively), confirming that the effects of σ1R were not caused by 
nonspecific accumulation of ER proteins. Furthermore, in cells 
coexpressing Orai1-EGFP, σ1R-mKate, and HA-STIM1, Orai1-
EGFP and σ1R-mKate accumulated into colocalized puncta 
after thapsigargin treatment, but neither formed puncta in the 
absence of STIM1 (Fig. 5, F and G). These results demonstrate 
that after store depletion, σ1R accompanies STIM1 to ER–PM 
junctions, but σ1R slows the accumulation of STIM1.
In related experiments, HeLa cells expressing different 
combinations of σ1R-EGFP, mCh-STIM1, and Orai1-Myc 
were fixed for immunolabeling, and confocal images were an-
alyzed to assess colocalization of the proteins before and after 
treatment with thapsigargin. As expected, in cells coexpressing 
STIM1 and Orai1, thapsigargin caused their colocalization to 
increase, consistent with evidence that clustered STIM1 at ER–
PM junctions captures Orai1 as it diffuses within the PM (Wu et 
al., 2014). In contrast, when σ1R and Orai1 were coexpressed, 
their colocalization was enhanced by store depletion only in the 
presence of STIM1, and overlapping puncta of all three proteins 
were then apparent at the cell periphery (Fig. 5, H and I). These 
results agree with those obtained using TIRF microscopy and 
demonstrate the importance of STIM1 in recruiting both Orai1 
and σ1R to the same junctions.
σ1R reduces the association of STIM1 
with PM Orai1
The requirement for STIM1 in recruiting σ1R to ER–PM junc-
tions containing Orai1 was investigated further by expressing 
σ1R-FLAG and Orai1-Myc with and without HA-STIM1. After 
treatment with thapsigargin and cell surface biotinylation, PM 
protein complexes were purified using avidin. Immunoblotting 
showed that the amount of σ1R within the biotinylated sample 
was significantly increased in cells overexpressing STIM1 and 
Orai1, but not when only Orai1 was overexpressed (Fig. 6, A 
and B). This indicates that STIM1 either promotes trafficking 
of σ1R to the PM, where it is directly biotinylated, or it pro-
motes association of σ1R with a biotinylated PM protein. Sim-
ilar analyses established that expression of σ1R-FLAG reduced 
the amount of STIM1 in the biotinylated sample to 47 ± 12% 
(n = 3) of that measured without σ1R (Fig. 6, C and D). The 
β-actin control showed no evidence of cell permeabilization 
or biotinylation of intracellular proteins. The biotinylated PM 
sample was subjected to a further round of purification using 
anti-Myc beads. Immunoblotting confirmed that when all three 
proteins were expressed, they were each captured in the final 
extract, suggesting that both STIM1 and σ1R are associated 
with the PM Orai1 channel complex (and that there is no need 
to invoke cell surface expression of σ1R to account for its pres-
ence in the biotinylated sample). The amount of STIM1 within 
this complex was again reduced by σ1R to 51 ± 7% of that mea-
sured without σ1R (Fig. 6, C and D). These results indicate that 
σ1R reduces the amount of STIM1 bound to PM Orai1. This 
was confirmed by purifying HA-STIM1 with anti-HA beads: 
Figure 4. Ligands regulate association of σ1R with STIM1. (A and B) Solubilized HEK cells expressing STIM1-Myc, σ1R-FLAG, or both were immunopre-
cipitated (IP) with anti-Myc (A) or anti-FLAG (B) antibodies before immunoblotting. Input lanes were loaded with 10 µl of the 500-µl sample and immuno-
precipitation lanes with 20 µl of the 50-µl eluate. (C and D) Similar immunoprecipitation analyses from cells expressing STIM1-Myc and σ1R-FLAG after 
pretreatment with 25 µM (+)SKF10047 or 10 µM BD1047. (E) Summary results (normalized to control cells; mean ± SEM; n = 3) show amounts of σ1R-FLAG 
immunoprecipitated by anti-Myc antibody in cells transiently expressing STIM1-Myc and σ1R-FLAG. **, P < 0.01. ANO VA with Tukey’s posthoc analysis.
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Figure 5. σ1R accompanies STIM1 to ER–PM junctions after store depletion. (A) Immunoblot of lysates from wild-type (WT) HEK, HEK-σ1R, or HeLa cells. 
The same amount of protein was loaded in each lane. (B) Confocal images of unstimulated HeLa cells transiently transfected with σ1R-EGFP and mCh-STIM1. 
Bar, 10 µm. (Right) Enlargement of the boxed area. Bar, 2.5 µm. (C and D) TIRF images of HeLa cells expressing mCh-STIM1 (C, top), σ1R-EGFP (C, bottom), 
or both (D) before and 10 min after addition of 5 µM thapsigargin in Ca2+-free HBS. (E, top) Traces show time courses of the fluorescence changes (F/F0) within 
the TIRF field after addition of thapsigargin (mean values for 30 puncta for each or size-matched regions of interest for σ1R alone). (E, bottom) Summary results 
show changes in mCh fluorescence (normalized to maximal intensity) after store depletion in cells with and without σ1R (n = 87). (F and G) TIRF images of 
HeLa cells expressing Orai1-EGFP and σ1R-mKate either with (F) or without HA-STIM1 (G). Bars (C, D, F, and G), 10 µm. (H) Confocal images of HeLa cells ex-
pressing σ1R-EGFP, HA-STIM1, and Orai1-Myc, immunostained after treatment with 5 µM thapsigargin. Boxed areas in the left panels (bar, 5 µm) are enlarged 
on the right (bar, 2 µm). Arrowheads show colocalization of all three proteins as white puncta at the PM. (I) Summary results (n = 8) show Mander’s overlap 
coefficient for colocalization of the indicated pairs of proteins in cells expressing only those tagged proteins or with σ1R-EGFP or HA-STIM1, as indicated, with 
and without thapsigargin treatment. **, P < 0.01; ***, P < 0.001, relative to resting cells. Student’s t test. Results show mean ± SEM.
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the amount of Orai1 that copurified with STIM1 was reduced in 
the presence of σ1R (Fig. 6 E).
If the reduction in STIM1 binding to Orai1 contributes 
to inhibition of SOCE by σ1R, we might expect increased 
expression of STIM1 to relieve the inhibition. We therefore 
tested the effects of overexpressing STIM1 on the amplitude 
of SOCE in wild-type HEK and HEK-σ1R cells. Expression of 
STIM1 produced a similar increase in the amplitude of SOCE 
in wild-type and HEK-σ1R cells, but the percent increase was 
greater in the HEK-σ1R cells (36 ± 5% in wild-type and 81 ± 
8% in HEK-σ1R cells; Fig. 6 F). This suggests that activation 
of SOCE is more limited by STIM1 in HEK-σ1R cells than in 
wild-type cells. The effects of STIM1 on SOCE were matched 
by its effects on Ca2+ stores: overexpression of STIM1 in-
creased the Ca2+ content of the stores, and the effect was greater 
in HEK-σ1R relative to wild-type cells (83 ± 7% and 18 ± 5% 
increases, respectively; Fig. 6 G). Furthermore, the effects of 
σ1R ligands on SOCE were much reduced in HEK-σ1R cells 
overexpressing STIM1 and Orai1 (Fig. S5). These results sup-
port the idea that σ1Rs inhibit the association of STIM1 with 
PM Orai1, thereby reducing SOCE (Fig. 6 H). Coincident with 
this inhibition of SOCE by σ1Rs, we invariably detected a de-
crease in the Ca2+ content of the ER.
σ1R inhibits binding of STIM1 to PM Orai1 
channel complexes
To examine the structure of the PM Orai1 channel complex in 
the presence and absence of σ1R, we used atomic force micros-
copy (AFM). Previous AFM images of complexes purified from 
cells overexpressing Orai1 and STIM1 showed a hexameric 
arrangement of STIM1 around a central Orai1 complex and a 
few strings of STIM1 molecules associated with Orai1, consis-
tent with the oligomerization of STIM1 after depletion of Ca2+ 
stores (Balasuriya et al., 2014b). We examined extracts from 
Figure 6. STIM1, Orai1, and σ1R interact within 
a macromolecular complex at the PM. (A) HEK 
cells expressing σ1R-FLAG alone or with Orai1-
Myc or Orai1-Myc and HA-STIM1 were treated 
with thapsigargin (5 µM for 30 min in Ca2+-free 
HBS), and then the cell surface was biotinylated. 
The representative immunoblot shows the inputs 
and the proteins detected after purification with 
avidin beads. Input lanes were loaded with 10 µl 
of the 500-µl sample, and surface biotinylation 
lanes were loaded with 10 µl of the 50-µl eluate. 
(B) Summary shows the amounts of σ1R-FLAG de-
tected in the avidin pull-downs (normalized to cells 
expressing only σ1R-FLAG). (C) HEK cells express-
ing Orai1-Myc and HA-STIM1 with or without 
σ1R-FLAG were cell surface biotinylated before se-
quential purification by elution from avidin-agarose 
with biotin and then from anti-Myc –agarose with 
Myc peptide. The immunoblot (anti-HA, anti-FLAG, 
anti-Myc, and anti–β-actin) shows the input and the 
two eluates. Input lanes were loaded with 10 µl of 
the 500-µl sample and elution lanes with 10 µl of 
the 50-µl eluate. (D) Summary shows the amounts 
of HA-STIM1 detected in the avidin (biotin elution) 
and anti-Myc pull-downs (normalized to Orai1-
Myc pull-down in each condition). (E) HEK cells 
expressing Orai1-Myc and HA-STIM1 with or with-
out σ1R-FLAG were immunoprecipitated (IP) with 
anti-HA antibody. (F) Peak [Ca2+]c signals evoked 
by SOCE were recorded from HEK or HEK-σ1R 
cells after treatment with thapsigargin (5  µM in 
Ca2+-free HBS for 10 min) and then restoration of 
4 mM extracellular Ca2+. The effects of transiently 
overexpressing STIM1 or Orai1 are shown. WT, 
wild type. (G) The Ca2+ contents of the intracellular 
stores of the same cells were measured by record-
ing peak increases in [Ca2+]c from cells exposed 
to ionomycin (5 µM in Ca2+-free HBS). Results (B, 
D, F, and G) are mean ± SEM. n = 3. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001, relative to control. 
ANO VA with Tukey’s posthoc analysis (B, F, and 
G) and Student’s t test (D). (H) The results suggest 
that STIM1 and σ1R within the ER are associated. 
When STIM1 is activated by depletion of the ER 
Ca2+ stores, STIM1 conveys σ1R to the PM, where 
STIM1 and Orai1 associate, trapping them within 
ER–PM junctions. The interaction between STIM1 
and Orai1 is weakened by σ1R.
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thapsigargin-treated HEK cells expressing Orai1-Myc/His and 
HA-STIM1, with or without σ1R-FLAG, in which cell surface 
proteins had been biotinylated and complexes were isolated by 
sequential purification using avidin and anti-Myc beads. AFM 
images showed large particles decorated by smaller peripheral 
particles (Fig. 7 A). The large central particle had the volume 
expected of hexameric Orai1 (566 ± 8 nm3; Fig. 7 B). A vol-
ume distribution of bound peripheral particles for the Orai1-
Myc/HA-STIM1 sample had two peaks at 131 ± 2 and 235 
± 4 nm3 (Fig.  7  C), consistent with the expected volumes of 
STIM1 monomers and dimers. For the Orai1-Myc/HA-STIM1/
σ1R-FLAG sample, the volume distribution of the peripheral 
particles had three peaks (62 ± 13, 130 ± 20, and 220 ± 22 nm3) 
corresponding to STIM1 monomers and dimers and a smaller 
peak consistent with the expected volume of σ1R monomers 
(∼63 nm3; Fig.  7  D). Of the 300 Orai1 complexes analyzed 
when expressed with STIM1 alone, 73 had bound particles 
and were either singly or doubly decorated. The total number 
of bound STIM1 was 96. From the 300 Orai1 complexes ana-
lyzed when coexpressed with STIM1 and σ1R, 76 had bound 
particles; there were 59 bound STIM1 and 46 bound σ1R. So 
the total number of bound STIM1 was reduced by 39% in the 
presence of σ1R. AFM images of Orai1 isolated from cells ex-
pressing Orai1 and STIM1 revealed, albeit with low frequency, 
that Orai1 bound to strings of STIM1 (Fig. 7 E). These assem-
blies were never seen in images from cells coexpressing σ1R. 
These results provide evidence for a PM complex of Orai1, 
STIM1, and σ1R and for reduced binding of STIM1 to Orai1 
in the presence of σ1R.
σ1R inhibits SOCE via STIM1 rather than 
by direct effects on Orai1
Reduced binding of STIM1 to Orai1 caused by σ1R is ex-
pected to reduce SOCE, but σ1R might also directly inhibit 
gating of Orai1 channels. To address this possibility, we used 
the channel-activating domain (CAD) of STIM1, which di-
rectly activates Orai1 (Muik et al., 2009; Park et al., 2009; Yuan 
et al., 2009; Gudlur et al., 2014). mCh-CAD expressed alone 
in HeLa cells was diffusely distributed in the cytoplasm, but 
it was peripherally distributed when coexpressed with Orai1, 
consistent with the constitutive association of CAD and Orai1 
(Fig. 8 A). Addition of extracellular Ca2+ to HEK or HEK-σ1R 
cells in Ca2+-free HBS had no significant effect on [Ca2+]c, but 
there was a substantial increase in [Ca2+]c in cells expressing 
CAD, consistent with constitutive activation of SOCE by CAD 
(Fig. 8, B and C). The response was indistinguishable in HEK 
and HEK-σ1R cells, suggesting that σ1R does not directly mod-
ulate PM expression of Orai1 nor its activity.
Discussion
We have shown that σ1Rs inhibit SOCE by decreasing the ef-
fectiveness with which empty stores stimulate Orai1. The target 
for regulation of SOCE by σ1R appears to be STIM1 (Fig. 8 D). 
σ1R and STIM1 colocalize in the ER; they can be coimmu-
noprecipitated before and after depletion of Ca2+ stores, and 
their interaction is regulated by σ1R ligands. The agonist, (+)
SKF10047, increases binding of STIM1 to σ1R and further 
Figure 7. AFM analyses of interactions be-
tween σ1R, STIM1, and Orai1 at the PM. 
(A) AFM images of Orai1 isolated with σ1R 
and STIM1 showing the central Orai1 (red 
arrowheads) channel decorated by either 
STIM1 (white arrowheads) or both STIM1 
and σ1R (blue arrowheads). (B–D) Frequency 
distributions of the volumes of the decorated 
central particles (Orai1; B), bound periph-
eral particles (STIM1) from cells expressing 
Orai1 and STIM1 (C), and bound peripheral 
particles (σ1R and STIM1) from cells express-
ing Orai1, STIM1, and σ1R (D). For these 
analyses, volume ranges of 30–100 nm3 and 
120–300 nm3 were set for σ1R and STIM1 par-
ticles, respectively; the intermediate volumes 
(100–120 nm3) were disregarded. (E) AFM 
images showing strings of STIM1 (white arrow-
head) connecting several Orai1 channels (red 
arrowhead). These infrequent structures were 
observed only in the absence of σ1Rs. Bars, 
20 nm; height scales, 0–3 nm (dark to light).
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inhibits SOCE, whereas the antagonist, BD1047, has the oppo-
site effects. After store depletion, σ1R translocates with STIM1 
to ER–PM junctions, but σ1R slows recruitment of STIM1 and 
reduces the amount of STIM1 bound to PM Orai1. This reduc-
tion in STIM1 binding to Orai1 suggests a likely mechanism for 
the inhibition of SOCE wherein σ1R accompanies STIM1 to 
ER–PM junctions, where it attenuates the interaction of STIM1 
with Orai1. The gap between the ER and PM at the junctions 
where SOCE occurs is probably too large (>9 nm; Várnai et al., 
2007) to be bridged by the short cytosolic loop of σ1R (Fig. S1; 
Hayashi and Su, 2007). The association of σ1Rs with PM Orai1 
is therefore likely to be mediated by STIM1. Reduced binding 
of STIM1 to Orai1 in the presence of σ1R may be caused by 
σ1R inhibiting the oligomerization of STIM1 or directly reduc-
ing the affinity of STIM1 for Orai1.
There are interesting similarities between the behavior of 
σ1Rs and that of other ER membrane proteins, including SAR 
AF (Palty et al., 2012) and POST (partner of STIM1; Krapivin-
sky et al., 2011). SAR AF also translocates to ER–PM junctions 
in a STIM1-dependent manner, and it promotes deactivation of 
STIM1 by antagonizing interactions between STIM1 molecules 
(Palty et al., 2012). Translocation of POST modulates SOCE-
evoked Ca2+ signals because it inhibits the PM Ca2+ pump that 
extrudes cytosolic Ca2+ (Krapivinsky et al., 2011). Hence, after 
loss of Ca2+ from the ER, STIM1 both activates SOCE and 
fine-tunes its activity by delivering additional Ca2+-regulating 
proteins to ER–PM junctions (Fig. 8 D). For σ1Rs, the effects 
of ER luminal Ca2+ on these delivery mechanisms may oper-
ate at two levels. Loss of ER Ca2+ (or a σ1R agonist) releases 
σ1R from its interaction with the ER luminal protein, BiP (Fig. 
S1; Hayashi and Su, 2007). Store depletion also causes STIM1 
to oligomerize and thereby gain affinity for ER–PM junctions. 
Depletion of Ca2+ stores may therefore both release σ1R from 
its ER tethers and, via its association with oligomeric STIM1, 
allow it to accumulate at ER–PM junctions. We focused on 
SOCE, but recruitment of σ1Rs to ER–PM junctions by STIM1 
might also be involved in regulation of other PM channels by 
σ1Rs (Maurice and Su, 2009; Su et al., 2010; Kourrich et al., 
2013; Pabba, 2013). For example, the L-type Ca2+ channel is 
inhibited by σ1R (Tchedre et al., 2008) and by depletion of in-
tracellular Ca2+ stores and STIM1 (Park et al., 2010; Wang et 
al., 2010). We suggest that STIM1-mediated translocation of 
σ1R to ER–PM junctions may inhibit voltage-gated Ca2+ entry 
and may also deliver σ1Rs to additional PM targets (Fig. 8 D).
Inhibition of SOCE by σ1Rs was invariably accompa-
nied by a decrease in the Ca2+ content of the ER with no evi-
dent change in [Ca2+]c. In contrast, and consistent with a study 
by López et al. (2012), inhibition of SOCE by expression of 
Orai1E106Q did not consistently affect ER Ca2+ content: it was 
normal in HEK cells but reduced in CHO cells. Inhibition of the 
STIM1–Orai1 interactions that mediate thapsigargin-evoked 
SOCE are not, therefore, sufficient to explain the effects of 
σ1Rs on ER Ca2+ content. It may be that σ1Rs also interact with 
STIM2, which plays a major role in maintaining the Ca2+ con-
tent of the stores (Brandman et al., 2007), or with other proteins, 
such as the sarco/ER Ca2+ ATPase, as was shown for orosomu-
coid-like 3 (Cantero-Recasens et al., 2010), or with Ca2+ chan-
nels that mediate Ca2+ uptake and release from the ER. For 
example, Sec61 mediates Ca2+ release from the ER, and it is in-
hibited by BiP (Schäuble et al., 2012). Expression of σ1R might 
sequester BiP (Fig. S1) and thereby enhance the Sec61-medi-
ated Ca2+ leak. The decreased Ca2+ content of the ER might also 
arise from σ1R stabilizing IP3R3 and thereby enhancing Ca2+ 
transport from the ER to mitochondria (Hayashi and Su, 2007).
The pathophysiological effects σ1Rs may, in part, result 
from inhibition of SOCE and the reduced Ca2+ content of the 
ER. The latter may affect protein folding (Hayashi and Su, 
2007) and inhibit apoptosis by preventing excessive Ca2+ trans-
fer to mitochondria (Maurice and Su, 2009; Giorgi et al., 2012). 
Figure 8. Translocation of Ca2+-regulating proteins to ER–PM junctions by 
STIM1. (A) Confocal images of unstimulated HeLa cells transiently trans-
fected with mCh-CAD alone (left) or with Orai1-CFP (right). Bars, 10 µm. 
(B) HEK or HEK-σ1R cells were mock transfected or transfected with CAD, 
and [Ca2+]c was recorded after addition of 1 mM BAP TA and then resto-
ration of 4 mM extracellular Ca2+. WT, wild type. (C) Summary results show 
peak [Ca2+]c signals evoked by restoration of extracellular Ca2+ (mean ± 
SD from six replicates). ***, P < 0.001, relative to control. Student’s t 
test. (D) Several proteins, including POST, σ1R, and SAR AF, associate with 
STIM1 in ER membranes (Krapivinsky et al., 2011; Palty et al., 2012). Loss 
of Ca2+ from the ER causes STIM1 molecules to oligomerize and become 
trapped, with their cargoes, in ER–PM junctions (green shading) as STIM1 
binds to phosphatidylinositol 4,5-bisphosphate and Orai1. STIM1 acti-
vates Orai1 and thereby SOCE. The proteins associated with STIM1 also 
regulate SOCE. SAR AF, by competing with STIM1, reduces STIM1 oligom-
erization and thereby contributes to the termination of SOCE (Palty et al., 
2012). σ1R competes with STIM1 for binding to Orai1, thereby inhibiting 
SOCE. POST associates with and inhibits the PM Ca2+ pump (PMCA) and 
thereby reduces local Ca2+ extrusion (Krapivinsky et al., 2011).
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The effects of σ1Rs on mitochondrial Ca2+ uptake are proba-
bly finely balanced because σ1Rs enhance delivery of Ca2+ to 
mitochondria at MAMs by stabilizing MAM-associated IP3Rs 
(Hayashi and Su, 2007), whereas our results show that σ1Rs 
reduce the ER Ca2+ content. The latter could explain the oth-
erwise surprising antiapoptotic effects of σ1Rs (Wang et al., 
2005; Maurice and Su, 2009; Decuypere et al., 2011; Crottès 
et al., 2013). The σ1R agonist, cocaine, was recently shown 
to attenuate SOCE in rat brain microvascular endothelial cells 
(Brailoiu et al., 2016). The neuroprotective effects of σ1R ago-
nists after ischemic injury (Katnik et al., 2006) and in patients 
with amyotrophic lateral sclerosis arising from loss-of-function 
mutations in σ1R (Al-Saif et al., 2011; Ono et al., 2014) may 
also, at least in part, be due to inhibition of SOCE. Hyperactive 
SOCE may contribute to the motor deficiencies in σ1R-knock-
out mice (Maurice and Su, 2009; Sabino et al., 2009; Mavlyutov 
et al., 2010) and to neurodegeneration in Alzheimer’s (Mishina 
et al., 2008; Ishikawa and Hashimoto, 2009; Hyrskyluoto et al., 
2013) and Parkinson’s diseases (Mishina et al., 2005; Hyrsky-
luoto et al., 2013; Francardo et al., 2014), where expression 
of σ1R is reduced. These suggestions prompt consideration 
of whether σ1R also interacts with STIM2 because it appears 
to play the major role in regulating SOCE in central neurons 
(Berna-Erro et al., 2009).
We conclude that σ1Rs inhibit SOCE because they asso-
ciate with STIM1, slow STIM1 recruitment to ER–PM junc-
tions, and reduce its binding to Orai1 after depletion of Ca2+ 
stores. Our study highlights a role for STIM1 in translocating 
σ1Rs to the PM and establishes σ1Rs and their ligands as im-
portant regulators of SOCE, a ubiquitously expressed Ca2+ 
entry pathway (Fig. 8 D).
Materials and methods
Materials
(+)SKF10047 and BD1047 were from Tocris Bioscience. Ionomycin 
was from MerckEurolab. Thapsigargin was from Alomone Labs. Anti- 
Myc monoclonal antibody (1:500 dilution for immunoblots; 46–0603), 
fura 2–AM, and fluo 4–AM were from Thermo Fisher Scientific. Anti- 
HA (1:500; 16B12) and anti-FLAG (1:500; F3165) monoclonal 
antibodies were from Covance and Sigma-Aldrich, respectively. The 
anti-σ1R antibody (1:200; Ab53852), which recognizes a sequence 
conserved in human and mouse σ1R, was from Abcam. Custom-made 
rabbit polyclonal antipeptide antisera to STIM1 (1:100; CDPQ HGH 
GSQ RDL TR; the Cys used for conjugation is underlined) and Orai1 
(1:200; CEFA WLQ DQL DHR GD) were prepared by Sigma-Aldrich. 
Anti-actin (1:500; A5441) antibody was from Sigma-Aldrich. Anti–
mouse (1:1,000) and anti–rabbit (1:1,000) HRP-conjugated secondary 
antibodies were from Thermo Fisher Scientific and Bio-Rad Labo-
ratories, respectively. Sources of additional materials are provided 
within the relevant methods.
Plasmids and siRNA
Plasmids encoding HA-STIM1 and Orai1-Myc/His6 have been de-
scribed previously (Willoughby et al., 2012; Balasuriya et al., 2014b). 
For mCh-STIM1, human STIM1 was subcloned into mCherry-C1 (Ta-
kara Bio Inc.) using XbaI and NotI. For σ1R-FLAG, σ1R was sub-
cloned into pcDNA3.1/FLAG using HindIII and AgeI. For σ1R-GFP, 
σ1R was subcloned into GFP-N1 (Takara Bio Inc.) using HindIII and 
KpnI. For σ1R-V5, σ1R was subcloned into pcDNA3.1/V5-His-TOPO 
using HindIII and AgeI. For σ1R-mKate, σ1R was subcloned into 
mKate2-N (Evrogen) using HindIII and KpnI. The coding sequences 
of all new constructs were verified. pDsRed2-Mito was from Takara 
Bio Inc. A pSIR EN vector encoding siRNA for σ1R (5′-GAT CCA 
CAC GTG GAT GGT GGA GTA TTC AAG AGA TAC TCC ACC ATC CAC 
GTG TTT TTT TGC TAG CG-3′) was used to inhibit expression of σ1R. 
pSIR EN encoding the luciferase gene was used as a negative control. 
Both pSIR EN constructs were gifts from T.-P. Su (National Institutes 
of Health, Bethesda, MD; Hayashi and Su, 2004). An expression plas-
mid (MO70) encoding a dominant-negative form of Orai1 in which 
Glu-106 is replaced by Gln (Orai1E106Q) was a gift from Y. Gwack and 
S. Srikanth (University of California, Los Angeles, Los Angeles, CA; 
Srikanth et al., 2012). The expression plasmid for mouse GFP-NFAT1 
was a gift from A. Parekh (University of Oxford, Oxford, England, UK; 
Kar et al., 2011). The mCh-STIM1 CAD expression plasmid was a 
gift from P. Hogan (La Jolla Institute for Allergy and Immunology, La 
Jolla, CA; Gudlur et al., 2014), and Orai1-CFP was from D.M.F. Coo-
per (University of Cambridge, Cambridge, England, UK).
Cell culture and transfection
All cells were maintained in DMEM with 10% fetal bovine serum and 
1% penicillin/streptomycin (Sigma-Aldrich) at 37°C in humidified air 
with 5% CO2. tsA 201 cells were grown to 70% confluence in a 162-
cm2 flask and transfected using calcium phosphate. 50 µg of plasmid 
DNA was mixed with 5 ml of 250 mM CaCl2 and diluted with 5 ml of 
medium comprising 275 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4, 
15 mM glucose, and 42 mM Hepes, pH 7.07. The mixture was added 
to the cells bathed in 25 ml of fresh growth medium. After 8 h, the 
medium was replaced with fresh growth medium. Cells were incubated 
for a further 48 h before being used for experiments.
HEK 293 cells were transfected using polyethylenimine. For 
cells grown to 70% confluence in 1 well of a 6-well plate, 1 µg of 
plasmid DNA was mixed with 2 µl of 7.5 mM polyethylenimine (Poly-
sciences, Inc.) and then diluted with 150 µl of serum-free DMEM. The 
mixture was incubated for 10 min at 20°C and then added to wells 
containing 2 ml of fresh growth medium for 48 h. The generation of a 
polyclonal HEK cell line stably expressing mouse σ1R-V5 (HEK-σ1R 
cells) was performed as described previously (Xu et al., 2012). These 
cells were maintained in medium supplemented with 0.8 mg/ml G418 
(Thermo Fisher Scientific).
HeLa cells were grown on poly-l-lysine–coated 25-mm glass 
coverslips and transfected using Lipofectamine 2000 (Thermo Fisher 
Scientific). For 1 well of a 6-well plate, 2 µg of plasmid DNA was 
diluted in 200 µl Opti-MEM and incubated at 20°C for 5 min. This was 
combined with 200 µl Opti-MEM containing 4 µl Lipofectamine 2000 
and left for a further 20 min at 20°C. The mixture was then added to 
cells in 2 ml of fresh medium. Cells were incubated for 48 h at 37°C 
and then used for experiments.
Measurements of [Ca2+]c
For measurements of [Ca2+]c in populations of cells, HEK cells were 
seeded into poly-l-lysine–coated 96-well plates. After 24 h, cells were 
incubated with 2 µM fluo 4–AM in HBS for 60 min at 20°C. HBS had 
the following composition: 150 mM NaCl, 10 mM KCl, 1 mM MgCl2, 
2 mM CaCl2, 10 mM glucose, and 10 mM Hepes, pH 7.3. In Ca2+-free 
HBS, Ca2+ was omitted, and 1 mM BAP TA was added. For treatments 
with (+)SKF10047 and BD1047, 10 mM stock solutions were prepared 
in DMSO and water, respectively. Cells were pretreated with 25 µM 
(+)SKF10047 or 10 µM BD1047 in serum-free DMEM for 1 h at 37°C 
before loading cells with fluorescent Ca2+ indicators. Drug treatments 
were continued during loading and throughout [Ca2+]c measurements. 
After loading, cells were washed and incubated in HBS for a further 
30 min at 20°C. Fluorescence (excitation at 490 nm and emission at 
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520 nm) was measured at 20°C using a plate reader that allows on-
line additions (FlexStation 3; Molecular Devices). Fluorescence was 
calibrated to [Ca2+]c from
  [  Ca 2+​ ]​c  =  K D ( F​−​​F​min  _ F max​−​​F ) ,  
where KD = 345 nM (KD = 190 nM at 37°C; Fig. S2 B), F is the mea-
sured fluorescence, and Fmax and Fmin are the fluorescence values deter-
mined after addition of 0.1% Triton X-100 in HBS with 10 mM Ca2+ or 
10 mM BAP TA, respectively.
Measurements of Mn2+ entry
Confluent cultures of HEK cells in 96-well plates were loaded with 
2 µM fura 2–AM using the method described for fluo 4. Fluorescence 
(excitation at 360 nm and emission at 510 nm) was measured using a 
plate reader (FlexStation 3) at 1.5-s intervals at 20°C. Quenching of 
fura 2 fluorescence (which reports unidirectional entry of Mn2+) is re-
ported as F/F0, where F is the fluorescence intensity recorded at each 
time and F0 is the mean fluorescence intensity measured in the 5 s be-
fore addition of MnCl2. Monoexponential curve fits to the time course 
of the changes in F/F0 were used to compute half-times (t1/2) for Mn2+-
evoked fluorescence quenching.
NFAT translocation assay
HEK cells were seeded onto poly-l-lysine–coated 25-mm coverslips, 
transfected with GFP-NFAT plasmid using polyethylenimine, and used 
after 48 h. The distribution of GFP fluorescence was measured before 
and 40 min after addition of 5 µM thapsigargin to cells at 37°C in HBS. 
Fluorescence (excitation at 488 nm and emission at 510–540 nm) was 
collected using a confocal microscope (SP5; Leica Biosystems) with 
an oil-immersion 40× objective (NA 1.25). Analyses of nuclear trans-
location of GFP-NFAT were performed with coded images, which were 
decoded only when the analysis was complete.
Analyses of protein expression
Cells were grown in 162-cm2 flasks. Where appropriate, cells were 
transfected with 50 µg of plasmid DNA using polyethylenimine. Cells 
were extracted in ice-cold medium (138 mM NaCl, 5 mM KCl, 1 mM 
Na2HPO4, 7.5 mM glucose, 21 mM Hepes, and 2 mM EDTA, pH 7.4) 
and centrifuged at 1,000 g for 5 min. Pelleted cells were solubilized at 
4°C for 60 min in Triton solution (TS) containing 25 mM Tris-HCl, 
150 mM NaCl, 10 mM EDTA, 1% Triton X-100, and 1 mg/ml protease 
inhibitor cocktail solution (Roche), pH 7.4, and samples were analyzed 
by SDS-PAGE followed by immunoblotting.
Immunoprecipitation analyses
tsA 201 cells, which are SV40-transformed HEK 293 cells, were used be-
cause they express heterologous proteins at high levels. Cells were grown 
in 162-cm2 flasks and transfected using calcium phosphate. Pretreat-
ments with (+)SKF10047 and BD1047 were for 2 h at 37°C, and stimula-
tion with 5 µM thapsigargin was for 30 min at 20°C. Cells were extracted 
in 25 ml of ice-cold medium, and all subsequent steps were performed at 
4°C. The suspension was centrifuged at 1,000 g for 5 min, and pelleted 
cells were solubilized for 60 min in 500  µl TS. After centrifugation 
(50,000 g for 60 min), 50 µl of the supernatant was removed for analysis 
of total expression (input), and 450 µl was incubated with 30 µl anti-Myc 
(EZ View Red) or anti-FLAG beads (Sigma-Aldrich) for 3 h with rota-
tion. Protein–bead complexes were isolated (20,800 g for 10 min) and 
washed three times in TS, and proteins were eluted either with 50 µl of the 
peptides (1 mg/ml; Sigma-Aldrich), to which the anti-Myc or anti-FLAG 
antibodies had been raised, or with 50 µl Laemmli buffer. The eluted 
samples were analyzed by SDS-PAGE followed by immunoblotting. 
For immunoblots, lanes were loaded with 10 µl of the 500-µl sample 
(2% of the entire sample) for the measurement of input and with 10 or 
20 µl of the 50-µl eluate for measurements of immunoprecipitation.
Isolation of surface biotinylated proteins
tsA 201 cells were grown in 162-cm2 flasks and transfected using cal-
cium phosphate. After appropriate stimulation, the medium was re-
moved and replaced with 12.5 ml of ice-cold HBS containing 0.2 mg/
ml biotin-sulfo-NHS (Thermo Fisher Scientific). After 60 min on ice, 
cells were washed three times with 15 ml Tris-buffered saline (25 mM 
Tris-HCl, 150 mM NaCl, and 10 mM EDTA, pH 7.4) and centrifuged at 
1,000 g for 5 min, and the pellet was solubilized in 500 µl TS for 60 min 
at 4°C. After centrifugation at 50,000 g for 60 min, the supernatant was 
incubated with 50 µl monomeric avidin-coated agarose beads (Thermo 
Fisher Scientific) at 4°C for 2 h. Protein–bead complexes were collected 
at 20,800 g for 10 min, washed three times in TS, and eluted with either 
50 µl Laemmli buffer for immunoblots or biotin (1 mg/ml in 1 ml TS) for 
further immunopurification using anti-Myc beads as described in the pre-
vious paragraph. For analyses of avidin pull-downs of biotinylated pro-
teins (Fig. 5, C–E), 2% of the total sample was loaded as input, and 40% 
of the Laemmli sample was loaded in the surface biotinylation lanes.
Immunostaining
HeLa cells were seeded on poly-l-lysine–coated glass coverslips, 
transfected, and used after 48 h. After stimulation, cells were washed 
with ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
and 2 mM KH2PO4), fixed with 4% paraformaldehyde for 20 min, and 
permeabilized with 0.5 mg/ml saponin for 60 min (Sigma-Aldrich) in 
blocking solution (5% goat serum and 3% BSA in PBS). Cells were 
stained with primary antibody in blocking solution (PBS containing 
3% BSA and 5% goat serum) for 60 min at 20°C, washed twice with 
PBS, and then incubated in the dark with secondary antibody in block-
ing solution for 60 min at 20°C, washed with PBS, dried, mounted onto 
a glass microscope slide, and stored at 4°C. Cells were imaged using 
an oil-immersion 60× objective (NA 1.40) using a confocal microscope 
(SP5; Leica Biosystems). For both Pearson’s and Mander’s coefficient 
measurements, images were analyzed with ImageJ (National Institutes 
of Health) using the JACoP plugin. For Mander’s coefficient, only pix-
els in which HA-STIM1 (or σ1R-EGFP) was detected were considered, 
and the fraction of those pixels in which Orai1-Myc was also detected 
was then computed to provide the colocalization coefficient.
TIRF microscopy
Coverslips were mounted on a TIRF microscope (IX51 inverted micro-
scope [Olympus] with a 100× oil-immersion objective [NA 1.49] cou-
pled to an electron-multiplying charged-coupled device camera [iXon; 
Andor Technology] and 488-nm argon ion and 561-nm diode lasers). 
Cells were incubated with HBS at 20°C and imaged (1 image/s) by ex-
citing σ1R-GFP at 488 nm (emission at 510–540 nm) and mCh-STIM1 
at 561 nm (emission at 610–650 nm). For each experiment, there were 
suitable controls, with cells expressing the EGFP-tagged protein alone 
and the mCherry/mKate-tagged protein alone to ensure there was no 
bleed through. For depletion of stores, cells were incubated with 1 µM 
thapsigargin in Ca2+-free HBS. Fluorescence intensities were quanti-
fied using the time series analyzer plugin V2.0 in ImageJ. Individual 
regions of interest within the cell were selected, and the data were an-
alyzed as F/F0, where F and F0 are the fluorescence intensities at each 
time and at the start of the experiment, respectively.
AFM
tsA 201 cells expressing appropriate combinations of Orai1-Myc-His, 
σ1R-FLAG, and HA-STIM1 were treated with thapsigargin, followed 
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by biotin-sulfo-NHS, and then purified using sequential avidin and 
anti-Myc affinity chromatography, as described in the Isolation of sur-
face biotinylated proteins section. About 45 µl of proteins was added to 
a 1-cm2 mica disk, incubated at 20°C for 10 min, gently washed with 
water, and dried under nitrogen. Samples were imaged in air using an 
atomic force microscope (Multimode; Bruker). The silicon cantilever 
(OTE SPA; Bruker) was set at a drive frequency of 271–321 kHz and 
spring constant of 12–103 N/m. The scan rate was 3 Hz, and the ap-
plied imaging force was kept as low as possible (target amplitude of 
1.0 V and amplitude set point of 0.7–1.0 V). Molecular volumes for 
individual particles were determined using an image processor (version 
5; Scanning Probe). For particles within complexes, particle heights 
(h) and radii (r) were measured manually using Nanoscope software. 
Particle volumes (Vm) were then calculated from
  V m =    
πh​( 3  r 2​+​​h​2 )  ________6 . 
Molecular volume (Vc), based on a known molecular mass 
(M0), was calculated from
  V c   =    
 M 0 ( V 1 +  dV 2 ) __________ N 0  , 
where N0 is Avogadro’s number, V1 is the specific particle volume (0.74 
cm3/g), V2 is the water specific volume (1 cm3/g), and d is the extent of 
hydration (assumed to be 0.4 g H2O/g protein).
Data analysis
Most results are presented as mean ± SEM from n independent exper-
iments. Statistical analysis used Student’s t test or analysis of variance 
(ANO VA) followed by Tukey’s posthoc test as appropriate.
Online supplemental material
Fig. S1 illustrates key features of σ1R, and Table S1 describes ligands 
targeting σ1R. Fig. S2 shows the effects of expressing σ1Rs in HEK 
cells on SOCE and the Ca2+ content of the intracellular stores. Fig. S3 
shows the effects of σ1R ligands on SOCE in CHO and HEK cells. 
Fig. S4 shows the effects of σ1R ligands on SOCE and the Ca2+ content 
of the intracellular stores in MDA-MB-231 human breast cancer cells. 
Fig. S5 shows the effects of σ1R ligands on SOCE in HEK-σ1R cells 
overexpressing STIM1 and Orai1. Online supplemental material is 
available at http ://www .jcb .org /cgi /content /full /jcb .201506022 /DC1.
Acknowledgments
We thank T.-P. Su for σ1R siRNA and control plasmids, S. Srikanth and 
Y. Gwack for the Orai1E106Q construct, A. Parekh for the GFP-NFAT 
plasmid, P. Hogan for the CAD construct, and D.M.F. Cooper for the 
Orai1-CFP construct.
S. Srivats is supported by the Cambridge International and European 
Trust, D. Balasuriya is supported by a David James bursary from the 
Department of Pharmacology, University of Cambridge, and G. Vistal 
is supported by the Jardines Matheson student bursary. This work was 
supported by grants to J.M.  Edwardson and R.D.  Murrell-Lagnado 
from the Biotechnology and Biological Sciences Research Council 
(BB/J018236/1 and BB/F001320/1) and by a grant from the 
Wellcome Trust (101844) to C.W. Taylor.
The authors declare no competing financial interests.
Submitted: 4 June 2015
Accepted: 24 February 2016
References
Al-Saif, A., F.  Al-Mohanna, and S.  Bohlega. 2011. A mutation in sigma-1 
receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 
70:913–919. http ://dx .doi .org /10 .1002 /ana .22534
Aydar, E., C.P.  Palmer, V.A.  Klyachko, and M.B.  Jackson. 2002. The sigma 
receptor as a ligand-regulated auxiliary potassium channel subunit. 
Neuron. 34:399–410. http ://dx .doi .org /10 .1016 /S0896 -6273(02)00677 -3
Aydar, E., P. Onganer, R. Perrett, M.B. Djamgoz, and C.P. Palmer. 2006. The 
expression and functional characterization of sigma (σ) 1 receptors in 
breast cancer cell lines. Cancer Lett. 242:245–257. http ://dx .doi .org /10 
.1016 /j .canlet .2005 .11 .011
Balasuriya, D., A.P.  Stewart, D.  Crottès, F.  Borgese, O.  Soriani, and 
J.M. Edwardson. 2012. The sigma-1 receptor binds to the Nav1.5 voltage-
gated Na+ channel with 4-fold symmetry. J.  Biol. Chem. 287:37021–
37029. http ://dx .doi .org /10 .1074 /jbc .M112 .382077
Balasuriya, D., L. D’Sa, R. Talker, E. Dupuis, F. Maurin, P. Martin, F. Borgese, 
O. Soriani, and J.M. Edwardson. 2014a. A direct interaction between the 
sigma-1 receptor and the hERG voltage-gated K+ channel revealed by 
atomic force microscopy and homogeneous time-resolved fluorescence 
(HTRF®). J.  Biol. Chem. 289:32353–32363. http ://dx .doi .org /10 .1074 /
jbc .M114 .603506
Balasuriya, D., S.  Srivats, R.D.  Murrell-Lagnado, and J.M.  Edwardson. 2014b. 
Atomic force microscopy (AFM) imaging suggests that stromal interaction 
molecule 1 (STIM1) binds to Orai1 with sixfold symmetry. FEBS Lett. 
588:2874–2880. http ://dx .doi .org /10 .1016 /j .febslet .2014 .06 .054
Berna-Erro, A., A.  Braun, R.  Kraft, C.  Kleinschnitz, M.K.  Schuhmann, 
D. Stegner, T. Wultsch, J. Eilers, S.G. Meuth, G. Stoll, and B. Nieswandt. 
2009. STIM2 regulates capacitive Ca2+ entry in neurons and plays a key 
role in hypoxic neuronal cell death. Sci. Signal. 2:ra67. http ://dx .doi .org 
/10 .1126 /scisignal .2000522
Brailoiu, G.C., E.  Deliu, L.M.  Console-Bram, J.  Soboloff, M.E.  Abood, 
E.M. Unterwald, and E. Brailoiu. 2016. Cocaine inhibits store-operated 
Ca2+ entry in brain microvascular endothelial cells: critical role for 
sigma-1 receptors. Biochem. J.  473:1–5.  http ://dx .doi .org /10 .1042 /
BJ2015093426467159
Brandman, O., J. Liou, W.S. Park, and T. Meyer. 2007. STIM2 is a feedback 
regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ 
levels. Cell. 131:1327–1339. http ://dx .doi .org /10 .1016 /j .cell .2007 .11 .039
Brune, S., S. Pricl, and B. Wünsch. 2013. Structure of the σ1 receptor and its 
ligand binding site. J.  Med. Chem. 56:9809–9819. http ://dx .doi .org /10 
.1021 /jm400660u
Cantero-Recasens, G., C.  Fandos, F.  Rubio-Moscardo, M.A.  Valverde, and 
R.  Vicente. 2010. The asthma-associated ORM DL3 gene product 
regulates endoplasmic reticulum-mediated calcium signaling and cellular 
stress. Hum. Mol. Genet. 19:111–121. http ://dx .doi .org /10 .1093 /hmg /
ddp471
Cárdenas, C., R.A.  Miller, I.  Smith, T.  Bui, J.  Molgó, M.  Müller, H.  Vais, 
K.H. Cheung, J. Yang, I. Parker, et al. 2010. Essential regulation of cell 
bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. 
Cell. 142:270–283. http ://dx .doi .org /10 .1016 /j .cell .2010 .06 .007
Chu, U.B., and A.E. Ruoho. 2016. Biochemical pharmacology of the Sigma-1 
receptor. Mol. Pharmacol. 89:142–153. http ://dx .doi .org /10 .1124 /mol 
.115 .101170
Cobos, E.J., J.M.  Entrena, F.R.  Nieto, C.M.  Cendán, and E.  Del Pozo. 
2008. Pharmacology and therapeutic potential of sigma1 receptor 
ligands. Curr. Neuropharmacol. 6:344–366. http ://dx .doi .org /10 .2174 
/157015908787386113
Crottès, D., S. Martial, R. Rapetti-Mauss, D.F. Pisani, C. Loriol, B. Pellissier, 
P.  Martin, E.  Chevet, F.  Borgese, and O.  Soriani. 2011. Sig1R protein 
regulates hERG channel expression through a post-translational 
mechanism in leukemic cells. J. Biol. Chem. 286:27947–27958. http ://dx 
.doi .org /10 .1074 /jbc .M111 .226738
Crottès, D., H.  Guizouarn, P.  Martin, F.  Borgese, and O.  Soriani. 2013. The 
sigma-1 receptor: a regulator of cancer cell electrical plasticity? Front. 
Physiol. 4:175. http ://dx .doi .org /10 .3389 /fphys .2013 .00175
Decuypere, J.P., G.  Monaco, G.  Bultynck, L.  Missiaen, H.  De Smedt, and 
J.B. Parys. 2011. The IP3 receptor-mitochondria connection in apoptosis 
and autophagy. Biochim. Biophys. Acta. 1813:1003–1013. http ://dx .doi 
.org /10 .1016 /j .bbamcr .2010 .11 .023
DeHaven, W.I., B.F. Jones, J.G. Petranka, J.T. Smyth, T. Tomita, G.S. Bird, and 
J.W. Putney Jr. 2009. TRPC channels function independently of STIM1 
and Orai1. J. Physiol. 587:2275–2298. http ://dx .doi .org /10 .1113 /jphysiol 
.2009 .170431
Francardo, V., F. Bez, T. Wieloch, H. Nissbrandt, K. Ruscher, and M.A. Cenci. 
2014. Pharmacological stimulation of sigma-1 receptors has 
neurorestorative effects in experimental parkinsonism. Brain. 137:1998–
2014. http ://dx .doi .org /10 .1093 /brain /awu107
 o
n
 April 26, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published April 11, 2016
JCB • Volume 213 • NumBer 1 • 201678
Giorgi, C., F.  Baldassari, A.  Bononi, M.  Bonora, E.  De Marchi, S.  Marchi, 
S.  Missiroli, S.  Patergnani, A.  Rimessi, J.M.  Suski, et al. 2012. 
Mitochondrial Ca2+ and apoptosis. Cell Calcium. 52:36–43. http ://dx .doi 
.org /10 .1016 /j .ceca .2012 .02 .008
Gromek, K.A., F.P.  Suchy, H.R.  Meddaugh, R.L.  Wrobel, L.M.  LaPointe, 
U.B.  Chu, J.G.  Primm, A.E.  Ruoho, A.  Senes, and B.G.  Fox. 2014. 
The oligomeric states of the purified sigma-1 receptor are stabilized by 
ligands. J. Biol. Chem. 289:20333–20344. http ://dx .doi .org /10 .1074 /jbc 
.M113 .537993
Gudlur, A., A.  Quintana, Y.  Zhou, N.  Hirve, S.  Mahapatra, and P.G.  Hogan. 
2014. STIM1 triggers a gating rearrangement at the extracellular mouth 
of the ORAI1 channel. Nat. Commun. 5:5164. http ://dx .doi .org /10 .1038 
/ncomms6164
Hayashi, T., and T.-P.  Su. 2003. Intracellular dynamics of σ-1 receptors (σ1 
binding sites) in NG108-15 cells. J. Pharmacol. Exp. Ther. 306:726–733. 
http ://dx .doi .org /10 .1124 /jpet .103 .051292
Hayashi, T., and T.-P.  Su. 2004. Sigma-1 receptors at galactosylceramide-
enriched lipid microdomains regulate oligodendrocyte differentiation. 
Proc. Natl. Acad. Sci. USA. 101:14949–14954. http ://dx .doi .org /10 .1073 
/pnas .0402890101
Hayashi, T., and T.-P. Su. 2005a. The sigma receptor: evolution of the concept in 
neuropsychopharmacology. Curr. Neuropharmacol. 3:267–280. http ://dx 
.doi .org /10 .2174 /157015905774322516
Hayashi, T., and T.-P. Su. 2005b. The potential role of sigma-1 receptors in lipid 
transport and lipid raft reconstitution in the brain: implication for drug 
abuse. Life Sci. 77:1612–1624. http ://dx .doi .org /10 .1016 /j .lfs .2005 .05 .009
Hayashi, T., and T.-P.  Su. 2007. Sigma-1 receptor chaperones at the ER-
mitochondrion interface regulate Ca2+ signaling and cell survival. Cell. 
131:596–610. http ://dx .doi .org /10 .1016 /j .cell .2007 .08 .036
Hogan, P.G., and A. Rao. 2015. Store-operated calcium entry: Mechanisms and 
modulation. Biochem. Biophys. Res. Commun. 460:40–49. http ://dx .doi 
.org /10 .1016 /j .bbrc .2015 .02 .110
Hoth, M., and B.A.  Niemeyer. 2013. The neglected CRAC proteins: Orai2, 
Orai3, and STIM2. Curr. Top. Membr. 71:237–271. http ://dx .doi .org /10 
.1016 /B978 -0 -12 -407870 -3 .00010 -X
Hyrskyluoto, A., I. Pulli, K. Törnqvist, T.H. Ho, L. Korhonen, and D. Lindholm. 2013. 
Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-
induced cell degeneration: involvement of calpastatin and the NF-κB pathway. 
Cell Death Dis. 4:e646. http ://dx .doi .org /10 .1038 /cddis .2013 .170
Ishikawa, M., and K.  Hashimoto. 2009. The role of sigma-1 receptors in the 
pathophysiology of neuropsychiatric diseases. J.  Receptor Ligand 
Channel Res. 2010:25–36. http ://dx .doi .org /10 .2147 /JRL CR .S8453
Ito, K., Y.  Hirooka, R.  Matsukawa, M.  Nakano, and K.  Sunagawa. 2012. 
Decreased brain sigma-1 receptor contributes to the relationship between 
heart failure and depression. Cardiovasc. Res. 93:33–40. http ://dx .doi .org 
/10 .1093 /cvr /cvr255
Ito, K., Y. Hirooka, and K. Sunagawa. 2013. Brain sigma-1 receptor stimulation 
improves mental disorder and cardiac function in mice with myocardial 
infarction. J.  Cardiovasc. Pharmacol. 62:222–228. http ://dx .doi .org /10 
.1097 /FJC .0b013e3182970b15
Kar, P., C. Nelson, and A.B. Parekh. 2011. Selective activation of the transcription 
factor NFAT1 by calcium microdomains near Ca2+ release-activated Ca2+ 
(CRAC) channels. J. Biol. Chem. 286:14795–14803. http ://dx .doi .org /10 
.1074 /jbc .M111 .220582
Katnik, C., W.R. Guerrero, K.R. Pennypacker, Y. Herrera, and J. Cuevas. 2006. 
Sigma-1 receptor activation prevents intracellular calcium dysregulation 
in cortical neurons during in vitro ischemia. J.  Pharmacol. Exp. Ther. 
319:1355–1365. http ://dx .doi .org /10 .1124 /jpet .106 .107557
Kilch, T., D. Alansary, M. Peglow, K. Dörr, G. Rychkov, H. Rieger, C. Peinelt, and 
B.A. Niemeyer. 2013. Mutations of the Ca2+-sensing stromal interaction 
molecule STIM1 regulate Ca2+ influx by altered oligomerization of 
STIM1 and by destabilization of the Ca2+ channel Orai1. J. Biol. Chem. 
288:1653–1664. http ://dx .doi .org /10 .1074 /jbc .M112 .417246
Kourrich, S., T.  Hayashi, J.-Y.  Chuang, S.-Y.  Tsai, T.-P.  Su, and A.  Bonci. 
2013. Dynamic interaction between sigma-1 receptor and Kv1.2 shapes 
neuronal and behavioral responses to cocaine. Cell. 152:236–247. http ://
dx .doi .org /10 .1016 /j .cell .2012 .12 .004
Krapivinsky, G., L. Krapivinsky, S.C. Stotz, Y. Manasian, and D.E. Clapham. 
2011. POST, partner of stromal interaction molecule 1 (STIM1), targets 
STIM1 to multiple transporters. Proc. Natl. Acad. Sci. USA. 108:19234–
19239. http ://dx .doi .org /10 .1073 /pnas .1117231108
Lewis, R.S.  2007. The molecular choreography of a store-operated calcium 
channel. Nature. 446:284–287. http ://dx .doi .org /10 .1038 /nature05637
Lewis, A., T.  Hayashi, T.-P.  Su, and M.J.  Betenbaugh. 2014. Bcl-2 family in 
inter-organelle modulation of calcium signaling; roles in bioenergetics 
and cell survival. J.  Bioenerg. Biomembr. 46:1–15. http ://dx .doi .org /10 
.1007 /s10863 -013 -9527 -7
Liou, J., M.  Fivaz, T.  Inoue, and T.  Meyer. 2007. Live-cell imaging reveals 
sequential oligomerization and local plasma membrane targeting of 
stromal interaction molecule 1 after Ca2+ store depletion. Proc. Natl. Acad. 
Sci. USA. 104:9301–9306. http ://dx .doi .org /10 .1073 /pnas .0702866104
López, E., G.M.  Salido, J.A.  Rosado, and A.  Berna-Erro. 2012. Unraveling 
STIM2 function. J. Physiol. Biochem. 68:619–633. http ://dx .doi .org /10 
.1007 /s13105 -012 -0163 -1
Lupardus, P.J., R.A. Wilke, E. Aydar, C.P. Palmer, Y. Chen, A.E. Ruoho, and 
M.B.  Jackson. 2000. Membrane-delimited coupling between sigma 
receptors and K+ channels in rat neurohypophysial terminals requires 
neither G-protein nor ATP. J. Physiol. 526:527–539. http ://dx .doi .org /10 
.1111 /j .1469 -7793 .2000 .00527 .x
Mallilankaraman, K., P. Doonan, C. Cárdenas, H.C. Chandramoorthy, M. Müller, 
R. Miller, N.E. Hoffman, R.K. Gandhirajan, J. Molgó, M.J. Birnbaum, 
et al. 2012. MICU1 is an essential gatekeeper for MCU-mediated 
mitochondrial Ca2+ uptake that regulates cell survival. Cell. 151:630–644. 
http ://dx .doi .org /10 .1016 /j .cell .2012 .10 .011
Maurice, T., and T.-P.  Su. 2009. The pharmacology of sigma-1 receptors. 
Pharmacol. Ther. 124:195–206. http ://dx .doi .org /10 .1016 /j .pharmthera 
.2009 .07 .001
Maurice, T., V.L. Phan, A. Urani, H. Kamei, Y. Noda, and T. Nabeshima. 1999. 
Neuroactive neurosteroids as endogenous effectors for the sigma1 (σ1) 
receptor: pharmacological evidence and therapeutic opportunities. Jpn. 
J. Pharmacol. 81:125–155. http ://dx .doi .org /10 .1254 /jjp .81 .125
Maurice, T., R. Martin-Fardon, P. Romieu, and R.R. Matsumoto. 2002. Sigma1 
(σ1) receptor antagonists represent a new strategy against cocaine 
addiction and toxicity. Neurosci. Biobehav. Rev. 26:499–527. http ://dx 
.doi .org /10 .1016 /S0149 -7634(02)00017 -9
Mavlyutov, T.A., M.L.  Epstein, K.A.  Andersen, L.  Ziskind-Conhaim, and 
A.E.  Ruoho. 2010. The sigma-1 receptor is enriched in postsynaptic 
sites of C-terminals in mouse motoneurons. An anatomical and 
behavioral study. Neuroscience. 167:247–255. http ://dx .doi .org /10 .1016 
/j .neuroscience .2010 .02 .022
Miki, Y., F.  Mori, T.  Kon, K.  Tanji, Y.  Toyoshima, M.  Yoshida, H.  Sasaki, 
A. Kakita, H. Takahashi, and K. Wakabayashi. 2014. Accumulation of 
the sigma-1 receptor is common to neuronal nuclear inclusions in various 
neurodegenerative diseases. Neuropathology. 34:148–158. http ://dx .doi 
.org /10 .1111 /neup .12080
Mishina, M., K.  Ishiwata, K.  Ishii, S.  Kitamura, Y.  Kimura, K.  Kawamura, 
K. Oda, T. Sasaki, O. Sakayori, M. Hamamoto, et al. 2005. Function of 
sigma1 receptors in Parkinson’s disease. Acta Neurol. Scand. 112:103–
107. http ://dx .doi .org /10 .1111 /j .1600 -0404 .2005 .00432 .x
Mishina, M., M.  Ohyama, K.  Ishii, S.  Kitamura, Y.  Kimura, K.  Oda, 
K. Kawamura, T. Sasaki, S. Kobayashi, Y. Katayama, and K.  Ishiwata. 
2008. Low density of sigma1 receptors in early Alzheimer’s disease. Ann. 
Nucl. Med. 22:151–156. http ://dx .doi .org /10 .1007 /s12149 -007 -0094 -z
Monnet, F.P. 2005. Sigma-1 receptor as regulator of neuronal intracellular Ca2+: 
clinical and therapeutic relevance. Biol. Cell. 97:873–883. http ://dx .doi 
.org /10 .1042 /BC20040149
Mori, T., T. Hayashi, E. Hayashi, and T.-P. Su. 2013. Sigma-1 receptor chaperone 
at the ER-mitochondrion interface mediates the mitochondrion-ER-
nucleus signaling for cellular survival. PLoS One. 8:e76941. http ://dx .doi 
.org /10 .1371 /journal .pone .0076941
Muik, M., M.  Fahrner, I.  Derler, R.  Schindl, J.  Bergsmann, I.  Frischauf, 
K. Groschner, and C. Romanin. 2009. A cytosolic homomerization and 
a modulatory domain within STIM1 C terminus determine coupling to 
ORAI1 channels. J.  Biol. Chem. 284:8421–8426. http ://dx .doi .org /10 
.1074 /jbc .C800229200
Navarro, J.F., D.  Beltrán, and M.  Cavas. 2012. Effects of (+) SKF 10,047, a 
sigma-1 receptor agonist, on anxiety, tested in two laboratory models in 
mice. Psicothema. 24:427–430.
Ono, Y., H. Tanaka, M. Takata, Y. Nagahara, Y. Noda, K. Tsuruma, M. Shimazawa, 
I.  Hozumi, and H.  Hara. 2014. SA4503, a sigma-1 receptor agonist, 
suppresses motor neuron damage in in vitro and in vivo amyotrophic 
lateral sclerosis models. Neurosci. Lett. 559:174–178. http ://dx .doi .org 
/10 .1016 /j .neulet .2013 .12 .005
Pabba, M.  2013. The essential roles of protein-protein interaction in sigma-1 
receptor functions. Front. Cell. Neurosci. 7:50. http ://dx .doi .org /10 .3389 
/fncel .2013 .00050
Palmer, C.P., R.  Mahen, E.  Schnell, M.B.A.  Djamgoz, and E.  Aydar. 2007. 
Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast 
cancer cell lines. Cancer Res. 67:11166–11175. http ://dx .doi .org /10 .1158 
/0008 -5472 .CAN -07 -1771
Palty, R., A.  Raveh, I.  Kaminsky, R.  Meller, and E.  Reuveny. 2012. SAR AF 
inactivates the store operated calcium entry machinery to prevent excess 
calcium refilling. Cell. 149:425–438. http ://dx .doi .org /10 .1016 /j .cell 
.2012 .01 .055
 o
n
 April 26, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published April 11, 2016
Sigma1 receptors inhibit store-operated Ca2+ entry • Srivats et al. 79
Parekh, A.B., and J.W.  Putney Jr. 2005. Store-operated calcium channels. 
Physiol. Rev. 85:757–810. http ://dx .doi .org /10 .1152 /physrev .00057 .2003
Park, C.Y., P.J. Hoover, F.M. Mullins, P. Bachhawat, E.D. Covington, S. Raunser, 
T.  Walz, K.C.  Garcia, R.E.  Dolmetsch, and R.S.  Lewis. 2009. STIM1 
clusters and activates CRAC channels via direct binding of a cytosolic 
domain to Orai1. Cell. 136:876–890. http ://dx .doi .org /10 .1016 /j .cell 
.2009 .02 .014
Park, C.Y., A.  Shcheglovitov, and R.  Dolmetsch. 2010. The CRAC channel 
activator STIM1 binds and inhibits L-type voltage-gated calcium 
channels. Science. 330:101–105. http ://dx .doi .org /10 .1126 /science 
.1191027
Prakriya, M., S. Feske, Y. Gwack, S. Srikanth, A. Rao, and P.G. Hogan. 2006. 
Orai1 is an essential pore subunit of the CRAC channel. Nature. 443:230–
233. http ://dx .doi .org /10 .1038 /nature05122
Rizzuto, R., D. De Stefani, A. Raffaello, and C. Mammucari. 2012. Mitochondria 
as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 
13:566–578. http ://dx .doi .org /10 .1038 /nrm3412
Robson, M.J., B.  Noorbakhsh, M.J.  Seminerio, and R.R.  Matsumoto. 2012. 
Sigma-1 receptors: Potential targets for the treatment of substance 
abuse. Curr. Pharm. Des. 18:902–919. http ://dx .doi .org /10 .2174 
/138161212799436601
Sabino, V., P. Cottone, S.L. Parylak, L. Steardo, and E.P. Zorrilla. 2009. Sigma-1 
receptor knockout mice display a depressive-like phenotype. Behav. 
Brain Res. 198:472–476. http ://dx .doi .org /10 .1016 /j .bbr .2008 .11 .036
Schäuble, N., S. Lang, M. Jung, S. Cappel, S. Schorr, Ö. Ulucan, J. Linxweiler, 
J. Dudek, R. Blum, V. Helms, et al. 2012. BiP-mediated closing of the 
Sec61 channel limits Ca2+ leakage from the ER. EMBO J. 31:3282–3296. 
http ://dx .doi .org /10 .1038 /emboj .2012 .189
Skuza, G., and Z. Rogóz. 2006. Effect of BD 1047, a sigma1 receptor antago-
nist, in the animal models predictive of antipsychotic activity. Pharmacol. 
Rep. 58:626–635.
Soboloff, J., B.S. Rothberg, M. Madesh, and D.L. Gill. 2012. STIM proteins: 
dynamic calcium signal transducers. Nat. Rev. Mol. Cell Biol. 13:549–
565. http ://dx .doi .org /10 .1038 /nrm3414
Spruce, B.A., L.A. Campbell, N. McTavish, M.A. Cooper, M.V.L. Appleyard, 
M. O’Neill, J. Howie, J. Samson, S. Watt, K. Murray, et al. 2004. Small 
molecule antagonists of the sigma-1 receptor cause selective release 
of the death program in tumor and self-reliant cells and inhibit tumor 
growth in vitro and in vivo. Cancer Res. 64:4875–4886. http ://dx .doi .org 
/10 .1158 /0008 -5472 .CAN -03 -3180
Srikanth, S., and Y.  Gwack. 2012. Orai1, STIM1, and their associating partners. 
J. Physiol. 590:4169–4177. http ://dx .doi .org /10 .1113 /jphysiol .2012 .231522
Srikanth, S., and Y. Gwack. 2013. Molecular regulation of the pore component of 
CRAC channels, Orai1. Curr. Top. Membr. 71:181–207. http ://dx .doi .org 
/10 .1016 /B978 -0 -12 -407870 -3 .00008 -1
Srikanth, S., H.J. Jung, K.D. Kim, P. Souda, J. Whitelegge, and Y. Gwack. 2010. 
A novel EF-hand protein, CRA CR2A, is a cytosolic Ca2+ sensor that 
stabilizes CRAC channels in T cells. Nat. Cell Biol. 12:436–446. http ://
dx .doi .org /10 .1038 /ncb2045
Srikanth, S., M. Jew, K.D. Kim, M.K. Yee, J. Abramson, and Y. Gwack. 2012. 
Junctate is a Ca2+-sensing structural component of Orai1 and stromal 
interaction molecule 1 (STIM1). Proc. Natl. Acad. Sci. USA. 109:8682–
8687. http ://dx .doi .org /10 .1073 /pnas .1200667109
Srikanth, S., B.  Ribalet, and Y.  Gwack. 2013. Regulation of CRAC channels 
by protein interactions and post-translational modification. Channels 
(Austin). 7:354–363. http ://dx .doi .org /10 .4161 /chan .23801
Stone, J.M., E.  Årstad, K.  Erlandsson, R.N.  Waterhouse, P.J.  Ell, and 
L.S. Pilowsky. 2006. [123I]TPC NE—a novel SPET tracer for the sigma-1 
receptor: first human studies and in vivo haloperidol challenge. Synapse. 
60:109–117. http ://dx .doi .org /10 .1002 /syn .2028116715498
Su, T.-P., T. Hayashi, T. Maurice, S. Buch, and A.E. Ruoho. 2010. The sigma-1 
receptor chaperone as an inter-organelle signaling modulator. Trends 
Pharmacol. Sci. 31:557–566. http ://dx .doi .org /10 .1016 /j .tips .2010 .08 .007
Tchedre, K.T., R.-Q. Huang, A. Dibas, R.R. Krishnamoorthy, G.H. Dillon, and 
T.  Yorio. 2008. Sigma-1 receptor regulation of voltage-gated calcium 
channels involves a direct interaction. Invest. Ophthalmol. Vis. Sci. 
49:4993–5002. http ://dx .doi .org /10 .1167 /iovs .08 -1867
Tsai, S.Y.A., M.J. Pokrass, N.R. Klauer, N.E. De Credico, and T.-P. Su. 2014. 
Sigma-1 receptor chaperones in neurodegenerative and psychiatric 
disorders. Expert Opin. Ther. Targets. 18:1461–1476. http ://dx .doi .org /10 
.1517 /14728222 .2014 .972939
van Waarde, A., A.A.  Rybczynska, N.K.  Ramakrishnan, K.  Ishiwata, 
P.H.  Elsinga, and R.A.J.O.  Dierckx. 2015. Potential applications for 
sigma receptor ligands in cancer diagnosis and therapy. Biochim. Biophys. 
Acta. 1848:2703–2714. http ://dx .doi .org /10 .1016 /j .bbamem .2014 .08 .022
Várnai, P., B. Tóth, D.J. Tóth, L. Hunyady, and T. Balla. 2007. Visualization and 
manipulation of plasma membrane-endoplasmic reticulum contact sites 
indicates the presence of additional molecular components within the 
STIM1-Orai1 complex. J.  Biol. Chem. 282:29678–29690. http ://dx .doi 
.org /10 .1074 /jbc .M704339200
Vilner, B.J., C.S. John, and W.D. Bowen. 1995. Sigma-1 and sigma-2 receptors 
are expressed in a wide variety of human and rodent tumor cell lines. 
Cancer Res. 55:408–413.
Walker, J.M., W.D.  Bowen, F.O.  Walker, R.R.  Matsumoto, B.  De Costa, and 
K.C. Rice. 1990. Sigma receptors: biology and function. Pharmacol. Rev. 
42:355–402.
Wang, B., R. Rouzier, C.T. Albarracin, A. Sahin, P. Wagner, Y. Yang, T.L. Smith, 
F. Meric-Bernstam, C. Marcelo Aldaz, G.N. Hortobagyi, and L. Pusztai. 
2004. Expression of sigma 1 receptor in human breast cancer. Breast 
Cancer Res. Treat. 87:205–214. http ://dx .doi .org /10 .1007 /s10549 -004 
-6590 -0
Wang, L., A.R.  Prescott, B.A.  Spruce, J.  Sanderson, and G.  Duncan. 2005. 
Sigma receptor antagonists inhibit human lens cell growth and induce 
pigmentation. Invest. Ophthalmol. Vis. Sci. 46:1403–1408. http ://dx .doi 
.org /10 .1167 /iovs .04 -1209
Wang, Y., X. Deng, S. Mancarella, E. Hendron, S. Eguchi, J. Soboloff, X.D. Tang, 
and D.L.  Gill. 2010. The calcium store sensor, STIM1, reciprocally 
controls Orai and CaV1.2 channels. Science. 330:105–109. http ://dx .doi 
.org /10 .1126 /science .1191086
Waterhouse, R.N., R.C.  Chang, N.  Atuehene, and T.L.  Collier. 2007. In vitro 
and in vivo binding of neuroactive steroids to the sigma-1 receptor as 
measured with the positron emission tomography radioligand [18F]FPS. 
Synapse. 61:540–546. http ://dx .doi .org /10 .1002 /syn .2036917447254
Willoughby, D., K.L.  Everett, M.L.  Halls, J.  Pacheco, P.  Skroblin, L.  Vaca, 
E. Klussmann, and D.M.F. Cooper. 2012. Direct binding between Orai1 
and AC8 mediates dynamic interplay between Ca2+ and cAMP signaling. 
Sci. Signal. 5:ra29. http ://dx .doi .org /10 .1126 /scisignal .2002299
Wu, Z., and W.D. Bowen. 2008. Role of sigma-1 receptor C-terminal segment in 
inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement 
of calcium signaling in MCF-7 tumor cells. J. Biol. Chem. 283:28198–
28215. http ://dx .doi .org /10 .1074 /jbc .M802099200
Wu, M.M., E.D. Covington, and R.S. Lewis. 2014. Single-molecule analysis of 
diffusion and trapping of STIM1 and Orai1 at endoplasmic reticulum-
plasma membrane junctions. Mol. Biol. Cell. 25:3672–3685. http ://dx .doi 
.org /10 .1091 /mbc .E14 -06 -1107
Wünsch, B. 2012. The σ1 receptor antagonist S1RA is a promising candidate for 
the treatment of neurogenic pain. J. Med. Chem. 55:8209–8210. http ://dx 
.doi .org /10 .1021 /jm3011993
Xu, X.J., M.  Boumechache, L.E.  Robinson, V.  Marschall, D.C.  Gorecki, 
M. Masin, and R.D. Murrell-Lagnado. 2012. Splice variants of the P2X7 
receptor reveal differential agonist dependence and functional coupling 
with pannexin-1. J. Cell Sci. 125:3776–3789. http ://dx .doi .org /10 .1242 
/jcs .099374
Yamamoto, H., J. Karasawa, N. Sagi, S. Takahashi, K. Horikomi, S. Okuyama, 
T.  Nukada, I.  Sora, and T.  Yamamoto. 2001. Multiple pathways of 
σ1 receptor ligand uptakes into primary cultured neuronal cells. Eur. 
J. Pharmacol. 425:1–9. http ://dx .doi .org /10 .1016 /S0014 -2999(01)01143 -8
Yuan, J.P., W.  Zeng, M.R.  Dorwart, Y.J.  Choi, P.F.  Worley, and S.  Muallem. 
2009. SOAR and the polybasic STIM1 domains gate and regulate Orai 
channels. Nat. Cell Biol. 11:337–343. http ://dx .doi .org /10 .1038 /ncb1842
 o
n
 April 26, 2016
jcb.rupress.org
D
ow
nloaded from
 
Published April 11, 2016
Sigma1 receptors inhibit store-operated Ca2+ entry • Srivats et al.
JCB
T
H
E
 J
O
U
R
N
A
L
 O
F
 C
E
L
L
 B
IO
L
O
G
Y
S17
Supplemental material
Srivats et al., http ://www .jcb .org /cgi /content /full /jcb .201506022 /DC1
Figure S1. Key features of σ1R. σ1R comprises 223 residues. It is expressed predominantly in ER membranes, where it adopts the topology shown with 
two transmembrane domains, a short cytosolic loop, and luminal N and C termini. The N terminus includes an ER retention signal. Residues important 
for ligand recognition are shown by the green oval. σ1Rs reside, along with some IP3Rs, within MAMs, regions of close contact between the ER and mi-
tochondria that allow Ca2+ and lipid exchanges between them (Hayashi and Su, 2004, 2007). IP3Rs associated with σ1Rs in MAMs are protected from 
degradation and can thereby deliver sustained physiological Ca2+ signals to mitochondria (Hayashi and Su, 2007). Within MAMs, σ1Rs also associate 
with the luminal Ca2+-binding protein and chaperone, BiP. The interaction between Ca2+-BiP and σ1R is disrupted by loss of Ca2+ from the ER or by σ1R 
agonists. This frees σ1Rs to move within ER membranes and establish contacts with different membranes, notably the PM (Hayashi and Su, 2007). The 
present study demonstrates that STIM1 can then deliver σ1Rs to specific PM domains.
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Figure S2. σ1Rs inhibit SOCE-mediated Ca2+ signals. (A) Experiments similar to those shown in Fig. 1 D were used to measure thapsigargin-evoked SOCE 
after restoration of different extracellular Ca2+ concentrations to wild-type (WT) HEK or HEK-σ1R cells. Results show peak increases in [Ca2+]c after resto-
ration of extracellular Ca2+ (concentrations refer to the free [Ca2+]; mean ± SEM; n = 3 with six replicates in each experiment). (B) Ca2+ signals evoked 
by thapsigargin and then restoration of extracellular Ca2+at 20°C or 37°C. Results show mean ± SD from six replicates. (C) Populations of fluo 4–loaded 
HEK cells transiently expressing σ1R-V5 (σ1Rtrans) or mock transfected (control) were stimulated with 5 µM thapsigargin in Ca2+-free HBS before addition 
of 4 mM extracellular Ca2+. Results show the mean ± SD of six replicates. (D) Experiments similar to those shown in Fig. 1 (G and H) were used to assess 
the size of the intracellular Ca2+ stores in HEK cells transiently expressing σ1R-V5. 5 µM ionomycin was added to cells in Ca2+-free HBS, and the peak 
increases in [Ca2+]c were recorded (mean ± SD from six replicates). (E) Populations of fluo 4–loaded HEK-σ1Rtrans or mock-transfected (control) cells were 
stimulated with 100 µM ATP and 100 µM carbachol in Ca2+-free HBS before addition of 4 mM extracellular Ca2+. Results show mean of six replicates. 
(F) Immunoblot showing σ1R expression at the indicated times after transfection. (G) Peak increases in [Ca2+]c evoked by SOCE recorded at the indicated 
times after transient transfection of HEK cells with σ1R. Results show mean ± SD from six replicates. **, P < 0.01; ***, P < 0.001, relative to control 
(Student’s t test in A and D and ANO VA followed by Tukey’s posthoc analysis in G). The results show that transient expression of σ1Rs has similar effects 
to stable expression, namely inhibition of SOCE and a reduction in the Ca2+ content of the intracellular stores.
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Figure S3. Time course of the effects of σ1R ligands on SOCE. (A) Populations of fluo 4–loaded CHO cells transiently transfected with Orai1E106Q or mock 
transfected were stimulated with 5 µM thapsigargin in Ca2+-free HBS before restoration of 4 mM extracellular Ca2+. Results show mean ± SD of six repli-
cates. (B and C) HEK-σ1R cells were pretreated with 10 µM BD1047 (B) or 25 µM (+)SKF10047 (C) for the indicated times, with the final 1.5 h at 20°C 
(during dye loading) and the preceding 1 h (for the 2.5-h incubation) at 37°C. Ca2+ signals evoked by thapsigargin in Ca2+-free HBS and then restoration 
of extracellular Ca2+ were recorded after the preincubations. (D) Summary results show peak increases in [Ca2+]c evoked by SOCE. (E) Experiments similar 
to those shown in Fig. 2 C were used to measure quenching of fura 2 fluorescence in CHO cells treated with siRNA to σ1R or with control plasmid. Fura 
2–loaded cells were treated with thapsigargin (5 µM for 10 min) in nominally Ca2+-free HBS before addition of 5 mM MnCl2. Results show normalized 
fluorescence intensity (F/F0) for six replicates. (F) Summary results show half-times (t1/2) for fluorescence quenching before (basal) and after thapsigargin 
treatment. The results demonstrate that loss of σ1Rs in CHO cells increases unidirectional entry of Mn2+ through the SOCE pathway. (G) Summary results 
show peak increases in [Ca2+]c evoked by SOCE after thapsigargin treatment (1 µM) in CHO cells transfected with siσ1R, Orai1E106Q, or both. (H) Typical 
traces show the effects of pretreatment with ligands of σ1R ((+)SKF10047, 25 µM; BD1047, 10 µM) on thapsigargin-evoked Ca2+ signals in HEK-σ1R cells 
treated with siRNA to σ1R. Fluo 4–loaded cells were stimulated with 5 µM thapsigargin in Ca2+-free HBS before restoration of 4 mM extracellular Ca2+. 
(I) Summary results show peak increases in [Ca2+]c evoked by 5 µM ionomycin. (J) Summary results show half-times (t1/2) for fluorescence quenching before 
(basal) and after treatment with thapsigargin (5 µM for 10 min) or carbachol with ATP (100 µM of each for 3.5 min). The results demonstrate that the effects 
of σ1R ligands on thapsigargin-evoked Ca2+ release and SOCE are abolished after treatment with siRNA for σ1R. (K) Fluo 4–loaded HEK-σ1R cells were 
incubated with 25 µM (+)SKF10047 or 10 µM BD1047 for 2 h in Ca2+-free HBS at 20°C. Thapsigargin (1 µM for 10 min) was added before or after addi-
tion of the σ1R ligands, and the increase in [Ca2+]c evoked by SOCE was measured after restoration of extracellular Ca2+. The results show that the ligands 
have less effect on SOCE when added after store depletion. *, P < 0.05; **, P < 0.01; ***, P < 0.001, relative to control (ANO VA followed by Tukey’s 
posthoc analysis for D, G, and I–K; Student’s t test for F and for comparison of no treatment conditions in I). (D and F–K) Results are mean ± SEM (n = 3).
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Figure S4. Effects of ligands of σ1R on SOCE and intracellular Ca2+ stores in MDA-MB-231 breast cancer cells. (A) Immunoblot showing detection of σ1R in 
a lysate of MDA-MB-231 cells. (B) Populations of fluo 4–loaded MDA-MB-231 cells were pretreated with 25 µM (+)SKF10047 or 10 µM BD1047 before 
addition of 5 µM thapsigargin in Ca2+-free HBS and then measurement of SOCE after restoration of 4 mM extracellular Ca2+ after 10 min. Results show the 
peak [Ca2+]c evoked by the addition of extracellular Ca2+. (C) The Ca2+ content of the intracellular stores was assessed after the same pretreatments with 
σ1R ligands by addition of 5 µM ionomycin in Ca2+-free HBS. Results show the peak increases in [Ca2+]c evoked by ionomycin. **, P < 0.01; ***, P < 
0.001, relative to control treatment (ANO VA followed by Tukey’s posthoc analysis). Results are mean ± SEM (n = 3).
Figure S5. Effects of ligands of σ1R on SOCE in cells overexpressing STIM1 and Orai1. Populations of fluo 4–loaded HEK-σ1R cells were either mock 
transfected (control) or transfected with STIM1 and Orai1 before pretreatment with 25 µM (+)SKF10047 or 10 µM BD1047. SOCE was then measured 
by addition of extracellular Ca2+ to cells treated with thapsigargin in Ca2+-free HBS. Results (mean ± SD; six replicates) show the peak [Ca2+]c evoked by 
addition of extracellular Ca2+. **, P < 0.01, relative to no treatment, using ANO VA followed by Tukey’s posthoc analysis.
Sigma1 receptors inhibit store-operated Ca2+ entry • Srivats et al. S21
Table S1. Ligands targeting σ1R
Antagonists Agonists
BD1047 Cocaine
Haloperidol Dimemorfan
Metaphit Donepezil
NE100 DTG
Rimcazole Fluvoxamine
Ibogaine
Methamphetamine
N,N-dimethyltryptamine (DMT)
Panamesine
PPBP
PPCC
Selective for σ1R versus σ2R
Igmesine
MR22
(+)Pentazocine
PRE-084
SA4503
(+)SKF10047
Endogenous neurosteroids
Progesterone Dehydroepiandrosterone (DHEA)
Pregnenolone
This list is incomplete, but it illustrates the diversity of drugs that interact with σ1Rs, the overlap with drugs that are important in the clinic or as drugs of abuse, and drugs used 
in the present study (bold). The σ1R is probably unrelated to σ2R, although the two have overlapping pharmacology. Drug actions: cocaine, inhibitor of catecholamine uptake 
(Schwartz et al., 2010) and drug of abuse. Dimemorfan, centrally acting cough suppressant (Shin et al., 2005). Donepezil (Aricept), reversible inhibitor of acetylcholinesterase 
used to treat Alzheimer's disease (Ramakrishnan et al., 2014). DMT, hallucinogen and possible endogenous ligand of σ1Rs (Fontanilla et al., 2009). Fluvoxamine, selective 
serotonin reuptake inhibitor (SSRI) used to treat depression (Hindmarch and Hashimoto, 2010). Many other SSRIs are also agonists of σ1Rs. Haloperidol (Dozic and Serenace), 
dopamine D2 receptor antagonist used to treat schizophrenia and other psychotic disorders (Maurice and Su, 2009). Ibogaine, psychoactive natural product. Potential utility in 
treatment of drug craving (Mach et al., 1995). Igmesine, possible utility in treatment of depression (Kulkarni and Dhir, 2009). Methamphetamine (crystal meth and ice), stimu-
lates release of catecholamines and blocks their reuptake (Nguyen et al., 2005) and is a drug of abuse. Panamesine, possible utility in treatment of schizophrenia (Kulkarni and 
Dhir, 2009). Pentazocine, opioid analgesic. Closely related to SKF10047 (Hayashi and Su, 2005). Rimcazole, adverse effects prevented use as a potential anticancer therapy 
(Happy et al., 2015). BB1047, N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-2(dimethylamino)ethylamine; DTG, 1,3-di-o-tolylguanidone; Igmesine, (R)-(+)-N-cyclopropylmethyl-α-
ethyl-N-methyl-α-[(2E)-3-phenyl-2-propenyl]benzenemethanamine hydrochloride; MR22, (-)-methyl (1S,2R)-2-{[1-adamantyl(methyl)amino]methyl}-1-phenylcyclopropane- 
carboxylate; NE100, 4-methoxy-3-(2-phenylethoxy)-N,N-dipropylbenzeneethanamine hydrochloride; PPBP, 4-phenyl-1-(4-phenylbutyl)-piperidine maleate; PPCC, (S*,R*)-2-[(4-
hydroxy-4-phenyl-1-piperidinyl)methyl]-1-(4-methylphenyl)-cyclopropanecarboxylic acid methyl ester; PRE-084, 2-(4-morpholinethyl) 1-phenylcyclohexanecarboxylate hydrochlo-
ride; SA 4503, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)-piperazine dihydrochloride; (+)SKF10047, [2S-(2α,6α,11R*)]-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-
propenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride.
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